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ABSTRACT
Exploring the Antibacterial, Antioxidant, and Anticancer
Properties of Lichen Metabolites
Gajendra Shrestha
Department of Biology, BYU
Doctor of Philosophy
Natural products have been a significant source of new drugs, especially in treating
cancer, infectious diseases, hypertension, and neurological disorders. Although many natural
metabolites have been screened and yielded pharmaceutically important drugs, many potential
sources of natural product drug therapies still need to be investigated, including lichens.
Lichens are symbiotic systems consisting of a filamentous fungus and a photosynthetic
partner (an eukaryotic alga and/or cyanobacterium). Lichens produce an impressive variety of
unique secondary compounds and have been used as ingredients in folk medicines for centuries.
Demonstrated biological roles based on lichen chemistry include: antibiotics, anti-proliferative,
antioxidants, anti-HIV, anti-cancer, immunomodulation, and anti-protozoans. Although North
America is home to an impressive variety of lichen species, there is limited research to examine
the biological potentials of these lichens. The core goal of this dissertation research has been to
investigate some of the biological roles including, antibiotic, antioxidant, and anticancer
potentials using lichen crude extracts and their metabolites collected from various locations in
the United States.
Antibiotic screening of crude extracts of 36 lichen species demonstrated inhibitory effects
against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Methicillinresistant S. aureus (MRSA). Generally, acetone extractions were found to be more effective than
methanol extractions. It has also been shown that L. vulpina extract was bacteriocidal against
MRSA with a relatively slow kill rate that disrupts cell membrane integrity and cell division as
possible modes of action. Antioxidant screening of extracts from 11 lichen species, using the
Oxygen Radical Absorbance Capacity (ORAC) assay, showed that lichen extracts inhibited the
oxidative degradation of the fluorescent molecule (fluorescein-sodium salt) by the oxygen free
radical initiator AAPH (2,2'-azobis(2-aminidopropane) dihydrochloride Acetone extracts as well
as pure compounds from lichen species showed cytotoxic effects against Burkitt's lymphoma
(Raji) cells and a colon cancer cell line (HT29 and SW620). They decreased proliferation,
arrested cell cycle at various stages and force the cell to undergo apoptosis. The tested extracts or
pure compounds were not toxic to normal cells. In colon cancer apoptosis took place
independent of casapase-3.
The results of this dissertation showed that lichen compounds merits for further
investigation.
Keywords: lichen, antibacterial, anticancer, antioxidant, immunomodulation, secondary
metabolites, mode of action, cell cycle, apoptosis, MTT, bacteriolysis, transmission electron
microscopy
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Chapter 1: Background
Lichens are obligate symbiotic systems consisting of a filamentous fungus and a
photosynthetic partner (an eukaryotic alga and/or cyanobacterium), and in some cases nonphotosynthetic bacteria (Hodkinson & Lutzoni, 2009; Selbmann et al., 2010). Lichens are
ecologically diverse and are distributed from the tropics to the polar regions (Brodo et al., 2001).
The worldwide lichen flora is estimated to include approximately 18,500 species (Boustie &
Grube, 2005; Feuerer & Hawksworth, 2007) and cover about 8% of the earth’s land surface
(Ahmadjian, 1995). Lichens are one of the slowest growing symbiontic associations and
according to Coley (1988) slow growing organisms occupying low-resource habitats produce
higher levels of defense chemicals in order to defend themselves from various consumers. This is
certainly true in the case of lichens since they are known to produce more than a 1000 different
secondary metabolites. General functional categories of the various lichen compounds include:
protection against a large spectrum of microbes, animal predators and plant competitors; defense
against environmental stress like UV radiation and desiccation; physiological regulation of
metabolism, such as the ability to increase algal cell membrane permeability in order to increase
the flow of nutrients to the fungal component (Huneck & Yoshimura 1996). As lichens are
capable of protecting themselves from various microbes including bacteria, non-lichenized fungi,
and nematodes, the potential value of these metabolites for medicinal purposes is generating
increasing research interest.
Lichens produce two different types of metabolites; primary and secondary. Primary
lichen substances have structural functions and play essential roles in cellular metabolism,
similar to those in other fungi. Primary metabolites are intracellular in origin and are synthesized
independently by both symbionts. Primary compounds consists mainly of chitin (in hyphal

1

walls), lichenin, isolichenin, hemicellulose, pectins, disaccharides, polyalcohols, amino acids,
enzymes, pigments like algal chromophores: chlorophyll and, β-carotenes, xanthophylls, etc.
(Podterob, 2008). In contrast, secondary metabolites are produced exclusively by the fungal
partner and are exported outside the fungal hyphae and deposited as extracellular crystals in
different parts of the thallus, often in the upper cortex or in specialized structures such as fruiting
bodies (Fahselt, 1994). Several studies have confirmed the exclusive fungal origin of secondary
metabolites (Culberson & Armaleo, 1992; Hamada et al., 1996; Kon et al., 1997; StockerWörgötter & Elix, 2002). Although lichen secondary metabolites are produced by the of fungal
partner, the metabolic interaction between the mycobiont and photobiont is essential to the
production of these secondary chemicals. This has been documented by studies where
mycobionts grown without the photobiont do not produce the same metabolites as the intact
lichen or produces a completely different suite of chemical products (Molina et al 2003; Fazio et
al 2009). There are some situations where the photobiont, especially cyanobacteria, also produce
some secondary metabolites (Cox et al., 2005; Yang et al., 1993).
Over 1050 secondary metabolites have been reported for lichens and aposymbiotically
cultured mycobionts (Molnar & Farkas, 2010). Among them a relatively small number (50 – 60)
are also produced by non-lichenized fungi or higher plants (Elix, 1996). One example is the
anthraquinone parietin which is present in other fungi like Aspergillus and Penicillium, as well as
in the vascular plant genera Rheum, Rumex and Ventilago (Romagni & Dayan, 2002). This
metabolic diversity is due largely to the symbiotic relationship between the lichen partners
(Lawrey, 1986). Lichen secondary products can comprise up to 20% of the thallus dry weight,
but in most lichens the amount varies from 5–10%.
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Natural products have been central in the discovery and development of various drug
therapies. It was Friedrich Sertürner who for the first time isolated a pharmacologically active
compound, morphine from opium produced by seed pods of the poppy plant, Papaver
somniferum (Hamilton & Baskett, 2000). Since then several thousand compounds have been
purified from various natural sources including plants, microorganisms, fungi etc. to treat various
diseases. According to Newman (2008) about 60% of the drugs that are now available come
either directly or indirectly from natural products. Natural products have been a significant
source of new drugs, especially in the treatment of cancer, infections, hypertension, and immune
and neurological disorders (Butler, 2004). Specifically in the development of anticancer drug
therapies, a number of important new commercialized drugs have been obtained from natural
sources. The search for improved cytotoxic agents continues to be an important endeavor in the
discovery of modern anti-cancer drugs (Gordaliza, 2007). Although many natural metabolites
have been screened and resulted in the production of many pharmaceutically important drugs
(Saleem et al., 2010), many potential sources of drug therapies still need to be investigated.
Among them are lichens.
North America is home to an impressive variety of lichen species. Many studies have
been published examining the taxonomical (Barton et al., 2014; Hutten et al., 2013),
phylogenetic (Leavitt et al., 2013), and ecological (Nelson et al., 2013) aspects of lichens in
North America; however, the biological roles of lichens have been poorly studied.
The main goal of this dissertation research has been to investigate the biological roles of
crude extracts and isolated metabolites of lichens collected from various regions of the United
States. The specific aims of this dissertation are as follows:
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1. Screen the acetone and methanol extracts of lichens against four pathogenic bacteria,
Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and methicillinresistant S. aureus.
2. Study the mechanism of action of lichen crude extracts against methicillin-resistant S.
aureus.
3. Investigate the antioxidant capacity of crude lichen extracts.
4. Screen and study the mode of action of acetone extracts and some purified lichen
metabolites against Burkitt’s lymphoma (Raji cells) and colon cancer cell lines (HT29
and SW620).
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Chapter 2: Biological roles of lichen-derived compounds: A review
Introduction
Lichens have been used as ingredients in folk medicines for centuries and many cultures
have used lichens to treat a variety of ailments as part of their traditional medicines (Dayan &
Romagni, 2001). The medicinal properties of some lichens are mentioned in the Ayurvedic and
Unani systems where they are used to treat a broad array of common ailments, including blood
and heart diseases, bronchitis, scabies, leprosy, asthma inflammations, stomach disorders, etc.
(Shukla et al., 2010). Recent advances in the medical field have resulted in exploration of the
biological activity of a limited number of lichen products with some studies suggesting that some
lichen chemicals could possible provide a promising source of future drug therapies (Shrestha
and St. Clair, 2013).
Demonstrated biological roles based on lichen chemistry include: antibiotics, antiproliferative, antioxidants, anti-HIV, anti-cancer, immunomodulation, and anti-protozoans.
Lichens produce an abundance of secondary compounds, and more than 1000 secondary
metabolites have been identified from intact lichens and aposymbiotically cultured mycobionts
(Molnar & Farkas, 2010). Production and regulation of lichen compound is complex and
variously influenced by environmental factors, including light, UV exposure, elevation,
temperature fluctuations, and seasonality. A review paper detailing the effects of different
environmental factors on lichen compounds have been published by Shrestha & St. Clair (2014).
As mentioned earlier, lichen compounds have multifaceted biological activities. This
chapter provides a review of antibiotic, anticancer, immunomodulatory, and antioxidant
activities of lichen compounds. The following tables will discuss the antibacterial, anticancer,
immunostimulant and antioxidant properties of lichen extracts and their metabolites.
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Table 2.1: A summary of the literature dealing with the antibiotic activity of lichen secondary chemistry.
Lichens/Lichen metabolites
Lobaric acid and lobastin
isolated from Stereocaulon
alpinum

Usnic acid, Atranorin,
Fumarprotocetraric acid

Bacteria
Bacillus subtilis
Staphylococcus aureus
Escherichia coli

Methicillin sensitive and
methicillin resistant
isolates of S. aureus

Combination of usnic acid and 5 20 different methecillin
different antibiotics namelyresistant clinical isolates
clindamycin, erythromycin,
of S. aureus
gentamicin, levofloxacin, and
oxacillin

Findings
Both the isolated compounds were found to
be active against B. subtilis and S. aureus.
The MIC values of Lobaric acid and lobastin
were 88 and 44 µM respectively against B.
subtilis while 39.6 and 35.2 µM respectively
against S. aureus. Both the compounds have
no effect on E. coli at the tested
concentrations.
Usnic acid showed the highest activity
against all the isolates. There as significantly
higher (at least eightfold) activity of usnic
acid as compared to atranorin.
Fumarprotocetratic acid did not showed
antibacterial activity in the tested
concentrations. The killing quotient
(MBC/MIC) suggested that usnic acid is
bacteriostatic in nature. However, atranorin
was found to be bactericidal in one of the
strains.
Usnic acid inhibited 50% of growth of all
S.aureus at 2 µg/ml while 90% growth
inhibition was found at 4 µg/ml.
Combination of usnic acid with gentamicin
gave synergistic action, while antagonism
was observed with levofloxin whereas there
was no difference with erythromycin.
However, variability was observed with
clindamycin and oxacillin.
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exhibited significant inhibitory activity
against all tested bacteria. The ethyl acetate
extract was most potent against E. coli with
MIC value of 15.62 µg/mL while methanolic
extract was active against B. subtilis and S.
aureus with the MIC value 15.62 µg/mL

Mycobacterium
tuberculosis

Several compounds were found to inhibit
growth of M tuberculosis; of which the most
active is diffractaic acid (MIC = 15.6 µg/mL)
followed by norstictic acid (MIC =
62.5µg/mL), usnic acid (MIC = 62.5µg/mL),
hypostictic acid (MIC = 94.0 µg/mL) and
protocetraric acid (MIC = 125 µg/mL).
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Usnic acid, norstictic acid,
salazinic acid, stictic acid,
diffractaic acid, barbatic acid,
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baileyi, Ramalina
dendriscoides, Stereocaulon
massartianum, and Cladonia
gracilis
Barbatic acid from Cladia
aggregata

B. subtilis
S.aureus
E. coli
Pseudomonas aeruginosa

Crude lichen extracts were very active
against Staphylococcus aureus and Bacillus
subtilis while moderately active against E.
coli and P. aeruginosa. Among the different
lichens, R. dendriscoides was the most active
against S. aureus with MIC and MBC values
of 156 μg/ml and 2500 μg/ml respectively.

Four multi drug-resistant
S. aureus strains

Barbatic acid either in crude organic form or
in purified form inhibited the growth of S.
aureus. The MIC values for purified barbatic
acid against different strains of
Staphylococcus aureus was 50µg/mL, except
for the highly resistant IC 404, whose MIC
was 100µg/mL.
Both crude extracts and individual fractions
showed activity against B. subtilis with usnic
acid having the highest MIC value of 1.2
µg/mL .S. aureus was inhibited by crude
extracts and usnic acid only but not by other
individual fractions. There was no effect of
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against E. coli and P. aeruginosa.

Crude extract and Usnic acid,
Usimine A, Usimine B, Usimine
C and Ramalin from Ramalina
terebrata

B. subtilis
S.aureus
E. coli
P. aeruginosa

Crude extract and 6 isolates (+)usnic acid, divaric acid, 2,4 –DiO-methyldivaric acid,
Divaricatinic acid, and 2-OMethylnordivaricatic acid from
Evernia divaricata

B. subtilis
S. aureus
E. coli
P. aeruginosa

Crude extracts showed a significantly high
inhibition zone against three species – B.
subtilis, S. aureus and P. aeruginosa. Usnic
acid and divaric acid showed very potent
inhibitory activity against the above
mentioned bacteria. This is first report
concerning the anti-bacterial properties of
divaric acid.
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Staphylococcus
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Aqueous extracts of most lichen showed
inhibition against B. subtilis, S. aureus and E.
coli while ethanol extracts of some lichens
were found to be active against B. subtilis, S.
aureus and S. epidermidis. Ethanolic extracts
of all tested lichens did not show any activity
against E. coli while both extracts were not
able to inhibit growth of K. pneumonia and
P. aeruginosa.

Physodic acid (Hypogymnia
physodes)
Usnic acid (Parmelia caperata)
Atranorin (Physcia aipolia)
Gyrophoric acid (Umbilicaria
polyphylla)

Bacillus mycoides
B. subtilis
Enterobacter cloacae E.
coli
K. pneumoniae
S. aureus

All the tested lichen substances inhibited
growth of all microorganisms with the lowest
recorded MIC (0.0037 mg/ml) against K.
pneumonia with usnic acid. Physodic acid
had the weakest activity level with an MIC
value of 1mg/ml

Evernic acid (Evernia prunastri)
Salazinic acid (Flavoparmelia
caperata)
Physodic acid (Hypogymnia
physodes)
3- hydroxyphysodic acid
(Hypogymnia physodes)
Usnic acid (Lecanora
albescens)
Hybocarpone (Lecanora
conizaeoides)
Atranorin (Lepraria lobificans)
Rhizocarpic acid (Psilolechia
lucida)

Methicillin - and
Multidrug-Resistant S.
aureus(SA-1199B)
Two hospital isolates of
resistant S. aureus
Norfloxacin -Susceptible
strain of S. aureus
Two epidemic MRSA
strain in UK

Most of the lichen compounds showed
consistent activity against various strains of
Staphylococcus aureus. Among the tested
extracts Hybocarpone was the most active
compound against all strains with an MIC
value of 4-8 ug/ml while Physcion and
salazinic acid showed no activity against any
of the strains at any concentration and
evernic acid and atronorin showed activity
against the Staphylococcus aureus-1199B
strain only.
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Karagöz et al., (2009)

Rankovic & Misic
(2008)

Kokubun et al., (2007)

Lobaric acid(Sterocaulon
dactylophyllum)
Physcion (Xanthoria parietina)
Crude extract of Rhizoplaca
chrysoleuca Rhizoplaca
melanophthalma Rhizoplaca
peltata

E. coli
Enterococcus faecalis
Proteus mirabilis
S.aureus
B. subtilis
B. megaterium
P. aeruginosa

Acetone extracts of R. chrysoleuca showed
high activity against all bacteria except P
.aeruginosa. While R. melanophthalma
extracts showed activity against only 3
bacteria. The zone of inhibition of R.
chrysoleuca was higher than antibiotic
tetracyclin in the case of E. coli, P. mirabilis
and B. megaterium.

Crude extract of
Parmelia saxatilis Platismatia
glauca
Ramalina pollinaria
Ramalina polymorpha
Umbilicaria nylanderiana

35 strains of bacteria

All extracts from five different lichens
species demonstrated antibacterial activity
against at least some of the bacterial species
tested. R. pollinaria, inhibited the most (11)
bacterial species. The maximum inhibition
zone forbacterial strains based on all lichen
extracts was<22 mm with MIC values
ranging from 6 - 62.5 ul/ml.

Usnic acid

S. aureus
P.aeruginosa

The capacity of usnic acid to control bio-film
formation by S. aureus or P. aeruginosa was
tested by loading the acid into modified
polyurethane. Usnic acid loaded polymers
did not inhibit the initial attachment of S.
aureus , but inhibited the formation of a biofilm by killing the attached cells where as in
P. aeruginosa there was no inhibition of biofilm formation but the morphology of the
biofilm was altered.
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Cansaran et al., (2006)

Gulluce et al., (2006)

Francolini et al.,
(2004)

Usnic acid (Cladonia arbuscula) Mycobacterium aurum
Atranorin (Stereocaulon alpinum)
Lobaric acid (S. alpinum)
Salazinic acid (Parmelia
saxatilis)
(+)-protolichesterinic acid
(Cetraria islandica)

Usnic acid is the most active compound with
an MIC value of 32 µg/mL while others were
inactive at the tested concentration.

(+)-Usnic acid (Commercial)
(-)-Usnic acid (Cladonia
stellaris)
Vulpinic acid (Letharia vulpina)

Lichen extracts inhibited the growth of S.
aureus, E. faecalis, E. faecium, and some
anaerobic species (Bacteroides and
Clostridium species) at the concentrations
tested. But gram negative bacteria were not
susceptible. Vulpinic acid generally was less
active than usnic acid. Susceptibility to usnic
acid was not impaired in clinical isolates of S.
aureus resistant to methicillin and/or
mupirocin.

10 different bacterial
strains and some resistant
strains of S.aureus

Crude and(-)-Usnic acid,
Physodic acid, 8'-O-Ethyl-palectoronic acid and
Alectosarmentin from Alectoria
sarmentosa

E. coli
S.aureus
Salmonella gallinarum
K. pneumoniae
Mycobacterium smegmatis
P. aeruginosa

Crude extracts as well as all isolated acids were
active against S. aureus and M. semgmatis but
not E. coli, S. gallinarum, K. pneumonia and P.
aeruginosa

17 species of lichens and
fractions from two lichens

Bacillus subtilis
Staphylococcus aureus
Escherichia coli
Pseudomonas aeruginosa

Extracts from the majority of the lichen species
studied were active against gram-positive
organisms and several against the gramnegative as well. Of the different fractions
Methyl 1-orsellinate had the lowest MIC value
against all microbes.
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Ingólfsdóttir et al.,
(1998)

Lauterwein et al.,
(1995a)

Gollapudi et al.,
(1994)

Ingolfsdottir et al.
(1985)

Table 2.2: A summary of the literature dealing with the anti-cancer activity of lichen secondary chemistry
Lichen Acid/Lichen species
Parmelia sulcata

Cell lines tested
Human Breast cancer cell
lines (MCF-7)
Human Breast cancer cell
lines (MDA-MB-231)

Major Finding
The methanolic extract of P. sulcata significantly
reduced the cell viability in dose-dependent
manner. The IC50 values for MCF-7 and MDAMB-231 were 39.1 and 16.5 µg/ml respectively.
They found increased in the expression of
caspase-cleaved cytokeratin 18 (M30), a wellknown marker of apoptosis, in MCF-7 but not in
MDA-MB-231 showing that the extract of P.
sulcata induced apoptosis. The induction of
apoptosis was caspase-independent as the
expression level of PARP and Caspase-3 remain
unchanged.

Reference

Ari et al., (2014)

Parmotrema reticulatum

Human breast carcinoma
(MCF-7) Human lung
carcinoma (A549)

The study showed that the methanolic extract of
P. reticulatum was cytotoxic against MCF-7 cells
with an IC50 value 130.03 µg/ml while there was
negligible cytotoxicity was observed on A549
and WI-38 ( normal lung fibroblast)cells. It was
further shown that the extracts arrested cell cycle
Ghate et al., (2013)
at S and G2/M phases and induces apoptosis in
dose as well as time dependent manner. There
was down-regulation of cyclin B1, Cdk-2 and
Cdc25C. There was increase Bax/Bcl-2 ratio
confirming the apoptosis.

Hypogymnia physodes

Human Breast cancer cell
lines (MCF-7)
Human Breast cancer cell
lines (MDA-MB-231)

The methanolic extract of H. physodes reduced
cell viability in dose dependent manner. The IC50
values for MCF-7 and MDA-MB-231 were 50
and 44 µg/ml respectively. Apoptosis was
observed only in MCF-7 but not in MDA-MB-
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Ari et al., (2014b)

231 as it was found M30-antigen level increased
in MCF-7 but remained unchanged in MDA-MB231. Nuclear fragmentation was also observed in
MCF-7 further confirming apoptosis. It was
further found that H. physodes was genotoxic at
higher concentrations (250 and 500 µg/ml)
Usnic acid (commercial)
Atranorin (commercial)
Parietin (Xanthoria parietina)
Gyrophoric acid (Umbilicaria
hirsuta)

Human ovarian
carcinoma A2780
Human colon
adenocarcinoma HT-29

Usnic acid and atranorin induced a massive loss
in the mitochondrial membrane potential, along
with caspase-3 activation in HT-29 cells but
externalization of phosphatidylserine occurred in
both tested cell lines. Cytotoxicity is mainly due
to induction of both ROS and especially RNS.
Usnic acid and atranorin activated programmed
cell death in A2780 and HT-29, probably through
the mitochondrial pathway.

Diffractaic acid (Protousnea
magellanica)
Vicanicin (Psoroma pallidum)
Lobaric acid (Stereocaulon
alpium)
Variolaric acid (Ochrolechia
deceptionis)
Protolichesterinic acid
(Cornicularia aculeate)
Usnic acid (Cladonia
lepidophora)

Human breast
adenocarcinoma MCF-7
Human colon
adenocarcinoma HCT116
Human cervix
adenocarcinoma HeLa

Lichen metabolites exhibited different cytotoxic
effects with higher susceptibility in HCT-116 and
less responsive in MCF-7. Among the 6
compounds, vicanicin did not showed any
activity against any of the cell lines in tested
concentration while only diffractaic acid and
usnic acid were active against all three cancer
cell lines. The apoptotic effect of
protolichesterinic acid was further evaluated
against HeLa cells by analyzing nuclear
morphology and measuring the activity of
caspase-3. 27% of apoptotic cells were found
after 72 hours of treatment and a significant
increase of caspase-3 activity was observed
compared to control cell confirming apoptosis.
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Backorová et al.
(2012)

Brisdelli et al.
(2012)

Atranorin (Bacidia stipata)
Diffractaic acid (Protousnea
magellanica)
Divaricatic acid (Protousnea
malacea)
Vicanicin (Psoroma
dimorphum)
Protolichesterinic acid
(Rhizoplaca melanophthalma)

Human prostate cancer
androgen-responsive
(LNCaP)
Human prostate cancer
androgen-non responsive
DU-145

Atranorin, diffractaic acid and divaricatic acid
were found to be active against prostate cancer
cells only in high concentration while vicanicin
and protolichesterinic acid showed dose –
dependent response causing apoptosis in both
types of cells. This study for the first time
showed that apoptosis induced by the compounds
appeared to be mediated, at least in part, via the
inhibition of Hsp70 expression.

Usnic acid (commercial)
Atranorin (commercial)
Parietin (Xanthoria parietina)
Gyrophoric acid (Umbilicaria
hirsuta)

Human ovarian
carcinoma A2780
Human breast
adenocarcinoma MCF-7
Human colon
adenocarcinoma HT-29
Human promyelocytic
leukemia
Human T cells
lymphocyte leukemia,
Jurkat
Human cervix
adenocarcinoma HeLa
Human breast
adenocarcinoma SK-BR3
Human colon carcinoma
wild type p53 HCT-116
p53+/+
Human colon carcinoma
p53 null HCT-116 p53-/-

Lichen compounds showed differential
sensitivity to various cancer cells. All the tested
compounds showed some cytotoxic activities but
usnic acid and atranorin were highly effective
against the whole spectrum of cell lines while the
other two were less effective. Similar to
cytotoxicity, usnic acid and atranorin also
significantly inhibited the clonogenic ability of
all the tested cell lines while the other two were
effective in some cervix and breast tumor cells.
All acids except parietin altered cell cycle
distribution accumulating cells in S-phase in all
tested cell lines, however, the efficiency and
spectrum of the affected cells were different.
Similarly, usnic acid and atranorin demonstrated
strong pro-apoptotic action while in other two
acids, the apoptotic index was less pronounced.
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Russo et al. (2012)

Backorová et al.
(2010)

Lecanoric acid and it’s
orsellinate derivatives

Larynx carcinoma HEP-2
Breast carcinoma MCF-7
Kidney carcinoma 786-0
Murine melanoma cell
B16-F-10
Vero cell

Structural modification of lecanoric acid
increased the cytotoxicity of the compound as
orsellinates derivatives have lower IC50 values
than lecanoric acid. n-Butly orsellinate was the
most active compound with IC50 values ranging
from 7.2 – 14.0 µg/ml. The orsellinate activity
has been found to increase with chain elongation
(from methyl to n-butyl), a likely consequence of
an increase in lipophilicity.

(+) Usnic acid (Cladonia
arbuscula)
(-) Usnic acid (Alectoria
ochroleuca)

Breast cancer cell line T47D
Pancreatic cancer cell
line Capan-2

Both (+) and (-) usnic acids are effective
inhibitors of DNA synthesis, with IC50values of
4.2 ug/ml and 4.0 µg/ml against T-47D and 5.3
µg/ml and 5.0 µg/ml against Capan-2. There
wasa reduction in cell size and both acids
inhibited cell entry into the S-phase. No
apoptosis was observed but necrosis was seen in
Capan-2. Usnic acid also caused loss of
mitochondrial membrane potential.

Retigeric acid A and Retigeric
acid B (Lobaria kurokawae)

Human Pca LNCaP
PC-3
DU 145
Human epidermoid
cancer KB and vincristine
resistant KB (KB/VCR)
Human ovarian cancer 3AO and cisplatin-resistant
3-AO (3-AO/CDDP)
Human benign prostate
epithelial RWPE1
Human hTERT-RPE1
Human breast cancer

Both Retigeric acid A (RA) and Retigeric acid
(RB) showed cytotoxicity at lower
concentrations (>100 uM) but RB is more potent
than RA. Structural analysis of RA and RB has
shown that a methyl side chain of RA is
substituted with –COOH in RB, suggesting a
possible structure–activity relationship. Further
investigation on the effect of RB on PC-3 cells
showed that RB caused a dose-dependent
accumulation of cells in the S phase
accompanied with decreases in cyclin B, and
increases in cyclin E and cyclin A. Both caspase
dependent and caspase-independent pathways
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Bogo et al., (2010)

Einarsdóttir et al.,
(2010)

Liu et al., (2010)

Olivetoric acid (Pseudevernia
furfuracea)

Usnic acid (Commercial)

(+) usnic acid
(Xanthoparmelia somloensis)
Salazinic acid
(Xanthoparmelia somloensis)
Vulpinic acid (Letharia
vulpina)
Gyrophoric acid (Lasallia
pustulata)
Evernic acid (Evernia
prunastri)

MCF-7
Human osteosarcoma
U2OS and Saos2

were responsible for apoptosis in PC-3 cells

Rat adipose tissue
endothelial cells

Olivetoric acid displayed dose dependent antiangiogenic activities, inhibited cell proliferation
and disrupted endothelial tube formation in
adipose tissue. Similarly, olivetoric acid also
inhibited the formation of actin stress fibers in a
dose dependent manner which may be due to the
decrease in tube formation.

Breast cancer cell lines
MCF7 (estrogendependent, wild-type
p53)
Lung cancer cell line
H1299 (null for p53)
Malignant mesothelioma
cells MM98
Vulvar carcinoma cells
A431
Keratinocytes HaCaT

No Morphological changes in microtubules or
increase in the mitotic index was observed
suggesting the antineoplastic activity of usnic
acid is not related to alterations in the formation
and/or stabilization of microtubules.
Usnic acid showed high toxicity for all three cell
lines while vulpinic acid was intermediately toxic
and salzinic, gyrophoric and evernic acids
showed low toxicity. The EC50 value of usnic
acid was significantly lower than anionic
surfactant SDS. Further, usnic acid and
gyrophoric acid showed strong wound closure
effects on HaCaT cells but the effect was less for
the other three acids. A combination of usnic
acid and gyrophoric acid further increased wound
closure rates.
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Koparal et al.,
(2010)

O'Neill et al.,
(2010)

Burlando et al.,
(2009)

Lethariella zahlbruckneri

16-O-Acetyl-leucotylic acid
Leucotylic acid (Both from
Myelochroa aurulenta)

Crude extract of
Evernia prunastri
Xanthoria parietina

Human colon cancer cell
(HT-29)

Human leukemia cells
HL-60

Murine myeloma P3X63Ag8.653

Both acetone and methanolic extracts of L.
zahlbruckneri decreased viable cell number in
both a time and dose dependent manner but an
acetone extract showed higher toxicity than the
methanolic extract. The acetone extract induced
cell death by increasing cell population in the
sub-G1 phase, as well as the formation of
apoptotic bodies and nuclear condensation while
such activities were not seen with the methanolic
extract. Apoptosis by the acetone extract was
induced both in a caspase-dependent and
caspase-independent manner. Apoptosis was
mitochondria mediated because there is increased
level of Bax and decreased level of the Bcl-2
protein.
16-O-Acetly-leucotylic acid exhibited potent
anti-proliferative activity against HL-60 with an
EC50 value of 21µM while the Leucotylic acid,
derivative of 16-O-Acetly-leucotylic acid has a
higher EC50value (72 µM). The antiproliferative properties of these two compounds
were higher than other similar compounds
(betulin and betulinic acid) derived from higher
plants. Structural modification has also been
found to affect the cytotoxicity of compounds
like Leucotylic acid which was less toxic than16O-Acetly-leucotylic acid.
A crude extract of Xanthoria parietina
significantly reduced cell proliferation in a dosedependent manner while no such activities were
seen with Evernia prunastri. The higher activity
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Ren et al., (2009)

Tokiwano et al.
(2009)

Triggiani et al.,
(2009)

of X. parietina may be due to the higher content
of antioxidants such as peroxidases and
superoxide dismutase.
Usnic Acid and its 9
derivatives

Lymphocytic leukemia
L1210
Murine Lewis lung
carcinoma 3LL
Chronic myeologenous
leukemia K-562
Brain metastasis of
prostate carcinoma DU
145
Breast adenocarcinoma
MCF 7
Glioblastom U251
Hamster cell lines: CHO
and CHO-MG

Usnic acid and its nine derivates were tested for
cytotoxicity. Four polyamine derivates showed
significant cytotoxicity on L1210 with an IC50
value significantly less than the parent compound
usnic acid. The most active compound (N-tertbutoxycarbonyl-1,8-diaminooctane) had an IC50
value of 2.7 uM and induced a dose-dependent
and time dependent apoptotic event in L1210.
The cytotoxicity of usnic acid can be improved
by its conjugation to a polyamine chain.

Sphaerophorin
(Sphaerophorus globosus)
Pannarin (Psoroma spp.)

Human melanoma cells
M14

Both sphaerophorin and pannarin showed
significant inhibitory effect on M14 cells at a
concentration of 12.5-50 uM. They also induced
apoptotic cell death substantiated by DNA
fragmentation and increased caspase-3 activity.

Crude extract of Cetraria
aculeata

Human uterus carcinoma
HeLa
Human small lung
carcinoma A549
Rrat embryonic fibroblast
5RP7
Normal rat embryonic
fibroblasts F2408

Acrude extract of C. aculeatawas found to be
cytotoxic against HeLa and A549 with an IC50
value of 200 and 500ug/ml respectively. The
extract also demonstrated higher cytotoxic
activity against F2408 and 5RP7 with IC50
values of 80 and 280 ug/ml respectively.
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Bazin et al., (2008)

Russo et al., (2008)

Zeytinoglu et (al.,
2008)

(+) Usnic acid (Ramalina
farinacea)
(-) Usnic acid (Cladonia
foliacea)

Chinese Hasmster Lung
fibroblast V79
Human lung carcinoma
A549

Both types of usnic acid showed dose and time
dependent cytotoxicity against V79 and A549
cell lines. Cytotoxicity was more pronounced in
A549 than V79 with cell viability more
diminished in A549 versus V79 after 2 days of
treatment

Sphaerophorin
(Sphaerophorus globosus)
Pannarin (Psoroma spp.)
Epiphorellic acid -1
(Cornicularia epiphorella)

Human prostrate
carcinoma DU 145
Normal human prostatic
epithelial cells

All compounds non-toxic to normal human
prostatic epithelial cells at aconcentration of 6-50
umol/l showed significant inhibitory effects on
DU-145 cells. Among the three compounds,
Pannarin showed the most activity. At lower
concentrations (12 and 25 µmol/l) all compounds
induced apoptosis but when the concentration
was increased to 50 µmol/l cell death was due to
necrosis as documented by a significant release
of lactic dehydrogenase. Apoptosis was further
confirmed by the large amounts of DNA
fragmentation in the 12 and 25 µmol/l
concentration but not in 50 µmol/l.

Usnic acid (Commercial)

Breast cancer cell lines
MCF7 (estrogendependent, wild-type
p53)
Breast cancer cell lines
MDA-MB-231 (estrogen
independent, mutant p53)

All three cell lines were sensitive to usnic acid
with IC50 values of 18.9 µM (MCF7) and 22.3
µM (MDA-MB-231 and H1299). There were
elevated levels of the p53 and p21 proteins
following treatment with usnic acid but there was
no p53 transcriptional activity suggesting that the
accumulation of p21 was not secondary to p53
transactivation.
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Koparal et al.,
(2006)

Russo et al., (2006)

Mayer et al.,
(2005)

(-) usnic acid
Fumarprotocetraric acid
9’-(O-methly)protocetraric
acid

Murine lymphocytic
leukemia L1210
Murine Lewis lung
carcinoma 3LL
Human chronic
myelogenous leukemia
U251
Human brain metastasis
of a prostate carcinoma
DU145
Human breast
adenocarcinoma MCF 7
Human glioblastoma
RCB-0461

Of the three compound tested only usnic acid
showed cytotoxic activity at IC50 values of 6,
12.1, 15.8, 17.8, 8.2 and 6.8 µg/ml for L1210,
3LL, DU145, MCF7, K-562 and U251
respectively. Usnic acid also induced apoptosis
in L1210 in a dose- and time-dependent manner
as fluorescence microscopy revealed
condensation of nuclear chromatin, nuclear
fragmentation, and formation of apoptotic
bodies.

Depsidones - Vicanicin,
Pannarin, 1-chloropannarin,
Salazinic acid, Stictic acid,
variolaric acid, Psoromic acid,
Fumarprotocetraric acid,
Lobaric acid
Depsides - Atranorin,
Sphaerophorin, Divaricatic
acid, diffractaic, gyrophoric
and usnic acid

Hepatocytes from rat

IC10 and IC50 values for 15 different lichen
compounds have been reported. Among them
Usnic acid has the highest cytotoxicity with an
IC50 value of 21 µg/ml after 24 hours which was
measured using lactic acid dehydrogenase.
Salazinic acid, stictic acid, and psoromic acid
showed apoptosis of hepatocytes in a dosedependent manner with stictic acid showing the
strongest apoptotic activity.

Cladonia convoluta
Cladonia rangiformis
Evernia prunastri
Parmelia caperata
Parmelia perlata
Platismatia glauca
Ramalina cuspidata

Murine lymphocytic
leukaemia L1210
Murine Lewis lun
carcinoma 3LL
Human chronic
myelogenous leukaemia
Human brain metastasis

3 different extracts, n-hexane, diethyl ether, and
methanol of 8 species were screened for
cytotoxicity against 7 cell lines. Significant
cytotoxicity (IC50≤ 20µg/ml) was found on one
of the tested cancer cell lines for at least one
extract of each lichen species. Crude extracts of
some of the lichens (C. convoluta, C.
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Bezivin et al.,
(2004)

Correche et al.,
(2004)

Bézivin et al.,
(2003)

Usnea rubicunda

of a prostate carcinoma
DU145
Human breast
adenocarcinoma MCF 7
Human glioblastoma
RCB-0461
African green monkey
kidney cell (Vero)

rangiformis, P. caperata, P. glauca,and R.
cuspidata had very high selectivity indices which
suggests a potential role as anti-tumor agents.

Pannarin
1'-chloro pannarin
Salazinic acid
Psoromic acid
Fumarprotocetaric acid
Lobaric acid
Vicanicin
Stictic acid
Variolaric acid
Atranorin
Sphaerophorin
Divaricatic acid
Diffractaic acid
Gyrophoric acid

Lymphocytes from
ratspleens

The screening of depsides and depsidones
revealed considerable cytotoxic effect for
Pannarin, 1’-chloropannarin, and sphaerophorin
with stronger effects than colchicine. Generally,
depsidones showed stronger cytotoxic activity
than depsides. The strong biological activity of
some depsidones may be due to the strong
hydrogen bond between the aldehyde group at C3
and the hydroxyl group at C4. Similarly, the
cytotoxic activity of depsides may be in part due
to the presence of a COOH group on C’1 and an
OH group on C’2.

(+)-usnic acid
Methyl â-orcinolcarboxylate
Ethyl hematommate
Diffractaic acid
Gyrophoric acid
(+)-protolichesterinic acid

Human keratinocyte cell
line HaCaT

Gyrophoric acid, usnic acid, and diffractaic acids
were reported as potent anti-proliferative agents
which inhibited cell growth at IC50 values of 1.7,
2.1, and 2.6 µM. However, the rest of the
compounds did not affect cell growth at
concentration of even 5µM. There was no release
of lactate dehydrogenase in the culture medium
suggesting no damage to the plasma membranes
of keratinocyte cells by lichen acids. This further
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Correche et al.,
(2002)

Kumar KC &
Müller (1999)

document that the effects of gyrophoric acid,
usnic acid, and diffractaic acid are cytostatic
rather than cytotoxic.
Lobaric acid (Stereocaulon
alpinum)
Protolichesterinic acid
(Cetraria islandica)

Breast cancer cell T-47D
and ZR-75-1
Erythro-leukemia K-563

Usnic acid derivatives

Lewis lung carcinoma
L1210

Both test substances caused a significant
reduction in DNA synthesis. Significant cell
deaths in all three cell lines were observed at
concentrations of 20 and 30 µg/ml of
protolichesterinic acid and lobaric acid
respectively. But DNA synthesis and
proliferation and survival of normal skin
fibroblasts were not affected at higher doses.
Eleven usnic acid derivatives where evaluated for
cytotoxicity against L1210 and seven derivatives
almost completely inhibited cell growth at
1.4X10-7 mol/mL while other derivatives showed
somewhat lesser cytotoxicity. The lipophilicity
and the β-triketone moiety of usnic acid were
found to be an important source of cytotoxicity.

Ogmundsdottir et
al. (1998)

Takai et al., (1979)

Table 2.3: A summary of the literature dealing with the immunomodulatory roles of lichen compounds
Lichen compound
Glucan from Umbilicaria
esculenta

Major Finding
This paper studies the effect of glucan on the phenotype and functional
maturation of dendritic cells. The authors found elevated expressions of
CD40, CD80, CD86, and MHC class I/II molecules confirming
phenotypic maturation of dendritic cells. They also discovered that there
was increased production of cytokines like IL-12, IL-1β, TNF-α, and
IFN-α/β, decreased endocytosis and enhanced proliferation of allogenic
T cells suggesting functional activation of dendritic cells. Finally, they
were able to show that glucan-induced dendritic cell maturation is related
to MAPK and NF-κB activation.
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Reference

Kim et al., (2010)

Methanolic extract from Caloplaca This study reports the tumorcidial activity of macrophages treated with
methanolic extracts of C. regalis. It was observed that there was an
regalis
increase in the tumorcidial activity of peritoneal macrophages against
B16 tumor cells in mice when treated with crude extracts (CR-ME). The
authors hypothesized that the increased tumorcidial activity of the
macrophages was due to elevated levels of NO and TNF-α. They further
speculated that the mechanism by which CR-ME activates macrophages
might involve p38 MAPK because there was abrogation of tumoricidal
effect of activated macrophages with a p38 MAPK inhibitor.
Lichenan and isolichenan from C.
islandica, as well as the secondary
metabolites, protolichesterinic and
fumarprotocetraric acids

This study reported the effect of lichen polysaccharides and secondary
metabolites on the maturation of human monocyte-derived immature
dendritic cells. Their effects on the maturation of dendritic cells.
Lichenan up-regulated the secretion of both IL-10 and IL-12p40 whereas
isolichenan and the two secondary metabolites showed no activity. The
authors also reported higher secretion rates for IL-10 when compared to
IL-12p40 which suggests that dendritic cells demonstrate tolerogenic
effects. The maturation of dendritic cells by lichenan may be due to
through DC-SIGN, a C-type lectin receptor.

Three heteroglycans Ths-4, Ths-5
and thamnolan and a β-glucan,
Ths-2, isolated from Thamnolia
vermicularis var. subuliformis

Ths-2, Ths-5, and thamnolan caused stimulation of rat spleen cell
proliferation but not by Ths-4 which caused cell death early in the
culture. Moreover, the secretion of IL-10 significantly higher when
treated with Ths-2, Ths-4, and Ths-5. In addition, Ths-4 and Ths-5
stimulated significant TNF-a secretion by rat peritoneal macrophages.
However, thamnolan did not induce the secretion of IL-10 by rat spleen
cells or TNF-a secretion by peritoneal macrophages to significant levels.

11 different polysaacharides
isolated from different species of
lichens

This study reports the effect of 11 different polysaccharides isolated from
various lichen species on the maturation of dendritic cells. Out of 11
polysaccharides, 8 of them showed some tendency towards upregulation
of IL-10 secretion by the dendritic cells and 4 of them, lichenan, Ths-2,
Pc-4 and thamnolan had significantly higher level of IL-10 production.
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Choi et al., (2009)

Freysdottir et al.
(2008)

Omarsdottir et al.
(2007)

Omarsdottir et al.
(2006)

Similarly, 7 polysaccharides upregulated with the production of IL12p40. Further the maturation of dendritic cells was confirmed by the
expression of CD86.
Three homogenic heteroglycans,
Pc-1, Pc-2, and Pc-3 and one
galactoglucomannan, Pc-4 isolated
from Peltigera canina

There was a dose-dependent increase in the proliferation of rat spleen
cells when treated with different polysaccharides with Pc-1 having the
highest stimulation index. All the polysaccharides also induced the
production of IL-10 by spleen cells. However, they stimulated only the
secretion of TNF-α but not IL-10 by peritoneal macrophages.

Galactomannan isolated from
Ramalina celastri (GMPOLY) and
galactomannan in combination
with the vanadyl ion (GMPOLYVO)

This study reported that both GMPOLY and GMPOLY-VO were capable
of diminishing the production of superoxide anions by macrophages
when triggered with Phorbol 12-myristate 13-acetate (PMA). They also
found that the diminution of superoxide anions production was lower in
case of GMPOLY-VO than GMPOLY suggesting that the complexing
with vanadyl ion led to the GMPOLY exacerbation the effects on the
macrophages. The superoxide anion production is protein kinase C
dependent; thus, the authors speculated that GMPOLY and GMPOLYVO could interfere but they have not neglected the possibility of their
scavenging properties. They also studied the effects of GMPOLY and
GMPOLY-VO on nitric oxide production and found that GMPOLY
enhanced nitric oxide (NO) production by 40% whereas no effect was
observed with GMPOLY-VO. NO has cytotoxic properties and protect
the host against potential pathogens. Hence this study suggests that
lichen-derived polysaccharides can indirectly protect host by stimulating
macrophages to produce nitric oxide.

α-D-glucan isolated from
Ramalina celastri

This paper describe the phagocytotic activities of α-D-glucan. They
injected a single intraperitoneal dose of α-D-glucan (200 mg/kg) to
female albino Swiss mice; killed at 7, 15, and 30 days to isolate
macrophages from peritoneal exudates and evaluated their phagocytotic
activity. They found that that after 7 days of treatment, phagocytosis was
increased by 70% and then started to decrease and finally leveled off
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with control by 30 days. This result indicates that the tested
polysaccharides have time dependent effect on the macrophage
phogocytotic activity.
Ci-3, an (1→3)-(1→4)-α-DGlucan extracted from Cetraria.
islandica

This paper had examined the phagocytotic activity of granulocytes
treated with Ci-3. The results have shown that there was increased in
phagocytotic activity in both in vitro and in vivo setting. This study had
also shown lichen polysaccharides can reduce the complement induced
hemolysis The functions of the complement system include opsonization,
chemotaxix and cell lysis; however, over-activation of the complement
system can contribute to the etiology of many inflammatory and autoimmune diseases such as rheumatoid arthritis, asthma, adult respiratory
distress syndrome, systemic lupus, and erythematosus

Water soluble polysaccharides
from C. islandica

This study found increased in the phagocytic activities of polysaccharide
treated granulocytes both in in vitro and in vivo setting. The anticomplementary assay showed the reduction of complementary-induced
hemolysis ranging from 49-85%.

KI-M-7, a galactomannaon,
isolated from C. islandica

This is the first study analyzing the immunostimulatory roles of
polysaccharide isolated from lichen. The results showed that human
granulocytes treated with KI-M-7, enhanced granulocytic phagocytosis
by 68% as compared to the control. Similarly, the in vivo phagocytotic
assay measured by calculating the rate of carbon clearance showed that
when KI-M-7 was administered intraperitoneally there was an increase in
the rate of carbon elimination by a mean ratio of 1.9 compared with the
control.
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Table 2.4: A summary of antioxidant properties of lichen
Lichens/Compounds
n-hexane, methanol and water
extracts from fourteen
saxicolous lichens

Main Findings
This study measured antioxidant capacity of 14 different lichen
species by measuring the ferric reducing antioxidant power (FRAP),
2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonicacid) diammonium
salt (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH) and nitric oxide
(NO) radical scavenging capacities and β-carotene-linoleic acid
bleaching property. All the lichen extracts had a good amount of total
proanthocyanidin, flavonoid and polyphenol. Methanolic extract
of Lobothallia alphoplaca exhibited highest FRAP value; methanolic
extract of Xanthoparmelia stenophylla had the highest ABTS radical
scavenging capacity; n-hexane extract of Rhizoplaca
chrysoleuca exhibited highest DPPH radical scavenging capacity;
water extract of Xanthoria elegans had the highest antioxidant
capacity in terms of β-carotene linoleic acid bleaching property; and
water extract of Melanelia disjuncta showed highest NO scavenging
capacity.

Lobaric acid and lobastin from
Stereocaulon alpinum

This study reports the isolation of new pseudodespidone, lobastin,
from S. alpinum collected from Antarctica. Antioxidant examination
by DPPH radical scavenging activity showed that lobaric acid did not
have scavenging activity whereas lobastin reduced DPPH free radicals
in dose-dependent manner. The authors speculated that the antioxidant
activity of lobastin might be due to the presence of double bond in
between C-8 and C-9, and opening of
heterocyclic ring.

Methanolic extract
from Parmotrema reticulatum
(PRME)

This study reports the antioxidant activities of PRME using different
methods. Total antioxidant activity of PRME, calculated as a function
of the trolox (standard) equivalent antioxidant capacity (TEAC), was
0.417±0.012. A dose dependent hydroxyl radical as well as
hypochlorous radical scavenging activity was observed and both these
activities were higher as compared to the respective standard
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compounds - Mannitol and ascorbic acid. It has also been shown that
PRME moderately scavenged superoxide, singlet oxygen radicals and
DPPH (2,2-diphenyl-1-picrylhydrazyl), a stable free radical.
Hexane extract of Ramalina
roesleri and nine isolated
compounds - Atranorin,
protolichesterinic acid, usnic
acid, 2-hydroxy-4-methoxy-6propyl benzoic acid,
homosekikaic acid, sekikaic
acid, benzoic acid, 2,4dihydroxy-6-propyl and 2,4dihydroxy-3,6-dimethyl
benzoate

This study measured antioxidant capacity of hexane extract of R.
roesleri and nine different isolated compounds. The DPPH radical
scavenging activity of extract ranged from 29.42% to 87.90%. Among
the isolated compounds activity sekikaic acid exhibited maximum
DPPH radical scavenging followed by homosekikaic acid.

Methanol and chloroform
extracts of Umbilicaria
cylindrica

This study demonstrated the antioxidant activities of methanolic and
chloroform extracts of U. cylindrical as measured by DPPH and
hydroxyl radical scavenging, chelating activity, and inhibitory activity
towards lipid peroxidation. Both methanol and chloroform extracts
had a good total phenolic contents as compared to Gallic acid
(Standard). Similarly the methanolic and chloroform extracts possess
antioxidant activity, with total antioxidant capacity of 74.65
±0.75μg AA/g and 71.32±0.87 μg AA/g, respectively (AA= Ascorbic
acid). The DPPH scavenging activity showed that both tested extracts
were able to scavenge this radical but the chloroform extract displayed
a higher activity than methanol extract.

Methanol extracts of the lichen
species Parmelia sulcata,
Flavoparmelia caperata,
Evernia prunastri, Hypogymnia
physodes and Cladonia foliacea

This study evaluated the antioxidant activities of methanol extracts of
five different lichen extract collected from southeast of Serbia by
measuring their DPPH radical scavenging activity. The results showed
that Hypogymnia physodes had the highest phenolic content and the
strongest DPPH radical scavenging effect.
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Ramalin from Ramalina
terebrata

This study compared antioxidant capacity of ramalin isolated from R.
terebrata against various commercially available standards. The
results showed that ramalin was five times more potent compared to
butylated hydroxyanisole (BHA) in scavenging 1-diphenyl-2-picrylhydazil (DPPH) free radicals, 27 times more potent in scavenging
2,2′-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid free radicals
(ABTS +) than trolox, the vitamin E analogue used commercially for
antioxidant, and 2.5 times more potent than BHT (Butylated
hydroxytoluene) in reducing Fe3+ to Fe2+ ions. Similarly, ramalin
was 1.2 times more potent than ascorbic acid in scavenging
superoxide radicals. It was also shown that ramalin is non-toxic to
human keratinocyte and fibroblast cells at its antioxidant
concentration

Hot water extracts of Lethariella
sernanderi, L. sinensis and L.
cashmeriana and four isolated
compounds

The antioxidant activities of hot water extracts and isolated
compounds were evaluated on the basis of Cu(II) reducing activity
and compared with quercetin (standard). Compound 3 (7chlororubrocashmeriquinone) showed the strongest activity among the
four isolated compounds suggesting that the 1,2-quinone and 7-Cl
moieties are important for antioxidant activity. The hot water extracts
of L. sernanderi had the highest antioxidant values among the crude
extracts.

15 individual compounds
extracted from Usnea articulata

This study reports the antioxidant activities of two new β-orcinol
depsidones together with 13 known compounds were isolated from U.
articulata. The newly reported β-orcinol depsidones along with
fumarprotocetraric acid exhibited moderate antiradical activity DPPH
assay. Two depsidones showed better superoxide anion scavenging
activity compared to the standard quercetin.
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Conclusion
Although lichens are one of the more promising reservoirs of low-molecular weight
secondary compounds demonstrating some level of biological activity; a very limited number of
compounds have been studied (Boustie & Grube, 2005). Hence, there is an urgent need for: 1)
continued screening of lichen metabolites across their diversity, 2) more in-depth studies of those
compounds that have already shown promising activity against pathogenic bacteria and/or
various cancer cell lines, 3) clinical trials for those compounds that have shown significant
activity, and finally 4) commercial production and implementation of effective drug lines.
One of the main issues related to the limited use of lichens compound in modern
medicine is related to their slow growth rate and challenges with in vitro propagation. However,
with recent advancements in technology, culturing lichens in the laboratory is achieving greater
success (Behera et al., 2006; Stocker-Wörgötter, 2001; Stocker-Wörgötter & Elix, 2002;
Yamamoto et al., 1993; Yamamoto et al., 1987; Yamamoto et al., 1985). Similarly, Miao et al.
(2001) reviewed the possibilities of using molecular genetics techniques as an alternative
approach for exploring the diversity of polyketide biosynthetic pathways in lichens. This
approach can be extended to examine other pathways which can then be integrated with
conventional culture methods. Also according to Miao et al. (2001) lichen genes can be
introduced into a surrogate host with good fermentation characteristics and a well characterized
endogenous chemical profile like Aspergillus nudulans, Neurospora crassa, Saccharomyces
cerevisiae, Escherichia coli, Streptomyces spp. etc. to produce promising lichen metabolites in
larger quantities. Furthermore, researchers have now been able to synthesize usnic acid in the
laboratory from commercially available starting materials. The synthesis involves the
methylation of phloracetophenone followed by oxidation with horseradish peroxidase (Hawranik
et al., 2009). This work also provided the impetus for synthesizing other lichen metabolites. With
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these recent advancements in technology, the development of cost effective options for growing
and harvesting lichen metabolites commercially as a source of effective drugs against pathogenic
bacteria and various forms of cancer show real promise.
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Chapter 3: Screening antibiotic properties of acetone and methanol extracts of thirty-six lichen
species
Introduction
The development of antibiotics in the 1940s provided a powerful tool for addressing
bacterial infections. However, due to the extensive use and misuse of antibiotic drugs in the
clinic, community, animal husbandry, and agriculture there is increased reemergence,
diversification, and spread of various resistant pathogenic bacteria (Andersson & Hughes, 2012).
Despite the need to effectively address antibiotic resistance, the discovery of new antibacterial
drugs has declined in recent years. The main reason behind the decline is largely because before
many drugs come to the market pathogens have already become resistant. The development of
antibiotic resistant variants of bacterial strain has severely impacted a drug’s long-term potential
to return a profit (Leeb, 2004). These issues emphasize the increasing importance of
investigating and developing new classes of antibiotics that are either opaque to pathogen
resistance or express a new mode of action, hence increasing the potential lifetime of the
antibacterial class (Kokubun et al., 2007).
Natural products continue to make a significant contribution to modern drug discovery
efforts (Newman & Cragg, 2007). Although more than 300 natural metabolites with
antimicrobial activities were reported between 2000 and 2008 (Saleem et al., 2010), many
potential sources of drug therapies still need to be investigated. Among them lichens are.
In this chapter the inhibitory activities of acetone and methanol extracts of 36 species of
lichens, collected from various locations in the United States, against four pathogenic bacterial
strains have been reported.
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Materials and methods
Collection of Lichen species
Thirty-six species of lichens were collected from various locations (June, 2010 to Aug,
2011) throughout the United States (Table 3.1). All voucher specimens have been deposited in
the Herbarium of Nonvascular Cryptogams at Brigham Young University (BRY-C) in Provo,
Utah, USA.
Extraction of lichen metabolites
Dried, cleaned lichen materials (4 g) were obtained from each of the 36 study species and
ground in liquid nitrogen. The ground samples were then extracted sequentially with acetone and
methanol. Sample extracts were dried under a stream of nitrogen gas, to reduce oxidation of
metabolites, and then dissolved in DMSO to a final concentration of 16 mg/ml. The stock
solution was stored at -20°C.
Identifying lichen metabolites
Lichen chemicals were identified using standard thin layer chromatography (TLC)
techniques in solvent system G (Orange et al., 2001). Solvent system G includes 139 ml toluene,
83 ml ethyl acetate, and 8 ml formic acid and was used to process the acetone extracts from all
lichen samples. The identity of individual lichen chemicals was inferred by comparison with the
published Rf values of known lichen secondary metabolites. (Orange et al., 2001). Usnic and
vulpinic acids were used as standards.
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Microbial Cultures
In this study, lichen extracts were tested against four strains of bacteria, namely
Escherichia coli (ATCC 11229), Pseudomonas aeruginosa (ATCC 27853), Staphylococcus
aureus (ATCC 6538P), and methicillin-resistant Staphylococcus aureus (S. aureus COL).
Micro-well Dilution assay
To quantify the biological activity of each lichen extract, minimum inhibitory
concentration (MIC) values were determined against all four bacterial strains using the microwell dilution assay method. Inocula were prepared by incubating a single colony of each
bacterial strain in 10 ml of Muller Hinton Broth (Sigma Aldrich, St. Louis, MO) at 37°C for 24
h. Serial dilutions of each lichen extract were prepared using Muller Hinton Broth with extract
concentrations ranging from 500-3.9 µg/ml in a 24-well plate. Four µl of an overnight culture of
one of the 4 bacterial strains was then added to individual wells. Then 100 µl of each extract
concentration was transferred to a 96-well plate in triplicate. Gentamycin and DMSO of
equivalent concentrations were used as a positive and vehicle control respectively. The plate was
then incubated for 24 h at 37°C. Following incubation 60 µl of p-iodonitrotetrazolium violet
(INT; Sigma-Aldrich, St. Louis, MO) was added to each well. Living bacteria will reduce the
INT dye and change the color of the solution from colorless to pink. The concentration at which
there was no reduction of INT represents the MIC value (Mann & Markham, 1998).
Table 3.1: List of 36 Lichen species with their collection site information.
Lichens

Collection Site

Alectoria imshaugii Brodo & D.
Hawksw.

Montana, Misoula Co., Flathead National Forest, vicinity of
Smith creek trailhead, near Bob Marshall wilderness area
boundary. 47° 33’ 11.18” N, 113° 40’ 2.64” W

Alectoria sarmentosa (Ach.) Ach.

Montana, Mission Mountain Wilderness Area, Cold lake
trailhead, 47° 33’ 39.6” N, 113° 51’ 19.5” W
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Bryoria fuscescens (Gyelnik) Brodo
& D. Hawksw.

Washington, Yakima County, Wenatchee National Forest,
Vicinity of Clear creek falls, in mixed conifer forest, 46° 39'
23.652" N, 121° 21' 7.524" W

Cladonia furcata (Hudson)
Schrader

Tennessee, Carter County, Cherokee National Forest, Along
Appalachian trail, 36° 10' 15.3" N, 82° 5' 57.78" W

Evernia prunastri (L.) Ach.

Washington, Klickitat County, North side of Columbia River
Gorge, in mixed oak/ponderosa forest, along Courtney Road
(off Highway 14, 2.6 miles East of Bingen, 45° 42' 0.2874" N,
121° 24' 27.18" W

Everniastrum catawbiense (Degel.)
Hale ex Sipman

Tennessee, Carter County, Cherokee National Forest, Along
Appalachian trail, 36° 6' 24.84" N, 82° 6' 32.46" W

Flavocetraria nivalis (L.) Kärnefelt
& Thell

Montana, Granite Co., Anaconda Pintler Wilderness Area, Goat
flat 46° 03’ 15.72” N 113° 16’ 38.22” W

Hypogymnia physodes (L.) Nyl.

Montana, Lewis and Clark Co., Lewis and Clark National
Forest, vicinity of south fork of sun river trailhead 47° 30’ 9.84”
N 112° 53’ 19.74” W

Letharia columbiana (Nutt.) J. W.
Thomson

Idaho, Elmore Co., Sawtooth national recreational area, along
Boise river, vicinity of Power plant recreational area (Near
Atlanta) 43° 48’ 59.22” N 115° 05’ 57.18” W

Letharia vulpina (L.) Hue

Idaho, Blaine County, Sawtooth National Recreational Area,
Vicinity of Alpine creek trailhead, 43° 53’ 53.04”N, 114°
54’25.62” W

Lobaria pulmonaria (L.) Hoffm.

Idaho, Idaho County, Clearwater National Forest, Along USFS
RD #362, South of fish hatchery, 46° 30’ 23.46” N, 114° 40’
52.08” W

Masonhalea richardsonii (Hooker)
Kärnefelt

Alaska, Fairbanks North Star County, Alpine tundra at Eagle
summit, north-west of parking area, Steese Highway, 65° 29’
12.12” N, 145° 24’ 55.08” W

Parmelia sulcata Taylor

Montana, Misoula Co., along Holland falls trail, near boundary
of Bob Marshall Wilderness Area 47° 27’ 10.98”N 113° 36’
16.98” W

Parmotrema reticulatum (Taylor)
M. Choisy

Montana, Mission Mountain Wilderness Area, Crystal lake
trailhead, 47° 20’ 1.38” N, 112° 43’ 48.24”W

Peltigera aphthosa (L.) Willd.

Montana, Powell County, Near Bob Marshall Wilderness Area
boundary, Vicinity of Pyramid Pass Trailhead and trail, 47° 15’
34.98” N, 113° 25’ 29.28” W
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Platismatia glauca (L.) W. L. Cul.
& C. F. Culb.

Montana, Mission Mountain Wilderness Area, Crystal lake
trailhead, 47° 20’ 1.38” N, 112° 43’ 48.24”W

Ramalina menziesii Taylor

California, Monterey County, Hasting Natural History
Reservation, 38601 E. Carmel Valley Road, Carmel Valley, 36°
22' 45.47" N, 121° 33' 58.47" W

Ramalina sinensis Jatta

Utah, Utah Co., Uinta NF., Along filth water hotspring, about
0.3 miles from trailhead, 40° 4’ 55.49” N 111° 21’ 8.32” W

Rhizoplaca chrysoleuca (Sm.) Zopf

Utah, Daggett County, Ashley National Forest, Fleming Gorge
National Recreational Area, Along Highway 191 at mile marker,
401, 40° 57' 53.24" N, 109° 32' 0.17" W

Rhizoplaca haydenii (Tuck.) W. A.
Weber

Wyoming, Sweetwater County, Ashley National Forest,
Fleming Gorge National Recreational Area, Along USFS Road
# 146 (Lucerne valley Recreational Road), 41° 0' 14.616" N,
109° 32' 11.2914" W

Rhizoplaca idahoensis Rosentreter
& McCune

Tennessee, Carter County, 9 miles south from Roan Mountain
State Park (TN 143S/Roan Road), Near Tennessee and North
Carolina boarder Along Appalachian trail, 36° 6' 28.38" N, 82°
6' 28.02" W

Rhizoplaca marginalis (Hasse) W.
A. Weber

California, Inyo County: Death Valley National Monument,
5.64 km northeast of Scotty's Caste; northeast cliffs face.

Rhizoplaca melanophthalma (DC.)
Leuckert & Poelt

Utah, Daggett County, Ashley National Forest, Fleming Gorge
national recreational area, vicinity of Red Canyon visitor center
40° 53’ 31.32” N, 109° 33’ 37.68” W

Rhizoplaca peltata (Ramond)
Leuckert & Poelt

Wyoming, Sweetwater County, Ashley National Forest,
Fleming Gorge National Recreational Area, Along USFS Road
# 146 (Lucerne valley Recreational Road), 41° 0' 14.616" N,
109° 32' 11.2914" W

Sphaerophorus globosus (Hudson)
Vainio

Oregon, Hood Co., Mount Hood Nation Forest, vicinity of
Tamanawas Falls Trailhead, on east fork of Hood River, in
conifer forest 45° 23’ 49.34” N 121° 34’ 19.16” W

Thamnolia vermicularis (Sw.) Ach.
ex Schaerer

Montana, Granite Co., Anaconda Pintler wilderness area, Goat
flat, 46° 3' 15.72" N, 113° 16' 38.22" W

Tuckermanopsis ciliaris (Ach.)
Gyelnik

Tennessee, Carter County, 9 miles south from Roan Mountain
State Park (TN 143S/Roan Road), Near Tennessee and North
Carolina boarder Along Appalachian trail, 36° 6' 24.84" N, 82°
6' 32.46" W

Umbilicaria americana Poelt & T.
H. Nash

Idaho, Custer County, Sawtooth National Forest, Sawtooth
National Recreational Area, Along USFS trail no. 101; at large
granite boulders. 44° 4’.45.06” N, 114° 58’ 57.42”
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Umbilicaria mammulata (Ach.)
Tuck.

Tennessee, Carter County, Roan Mountain State Park, Raven
Rock Trail, 36° 9' 57.54" N, 82° 5' 30.54" W

Usnea hirta (L.) F. H. Wigg.

Colorado, Garfield County, White River National Forest, Along
Cline Top Road, Forest Service Road 603, 39°40' 23.30" N,
107° 33' 23.07" W

Usnea lapponica Vainio

Colorado, Garfield County, White River National Forest, Along
Cline Top Road, Forest Service Road 603, 39°40' 23.30" N,
107° 33' 23.07" W

Usnea strigosa (Ach.) Eaton

Tennessee, Carter County., Near the vicinity of Roan Mountain
State Park visitor center, 36° 10' 14.04" N, 82° 5' 53.3" W

Vulpicida canadensis (Räsänen) J.E. Mattsson & M. J. Lai

Oregon, Clackamas County, In Ponderosa forest near small
stream along Highway 26, about 20 miles North of Warm
Springs 45° 0' 8.064" N, 121° 29' 32.3874" W

Xanthoparmelia chlorochroa
(Tuck.) Hale

Colorado, Routt County, Way to Kremmling from Toponas,
near the junction of Highway 134 and State Road # 206, 40° 4'
37.236" N, 106° 39' 43.776" W

Xanthoparmelia coloradoënsis
(Gyelnik) Hale

Colorado, Rio Blanco County, White River National Forest,
Along North Fork Road (205) Near the Trailhead Outlet, 40° 0'
9.0" N, 107° 13' 53.004" W

Xanthoparmelia wyomingica
(Gyelnik) Hale

Montana, Granite Co., Anaconda Pintler wilderness area, Goat
flat, 46° 3' 15.72" N, 113° 16' 38.22" W

Results
Identification of lichen metabolites
Major chemical compounds from lichen extracts are reported in Table 3.2.
Table 3.2: Lichen compounds identified using Thin Layer Chromatography
Lichens
Alectoria imshaugii
Alectoria sarmentosa
Bryoria fuscescens
Cladonia furcata
Evernia prunastri
Everniastrum catawbiense
Flavocetraria nivalis
Hypogymnia physodes
Letharia columbiana

Compounds
Usnic acid, Squammatic acid, Thamnolic acid
Usnic acid, Barbatic acid, Squammatic acid, Thamnolic acid
Fumarprotocetratic acid, Norstictic acid, Protocetraric acid
Fumarprotocetraric acid, Protocetraric acid
Atranorin, Evernic acid
Atranorin, Gyrophoric acid
Usnic acid
Barbatic acid
Vulpinic acid
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Letharia vulpina
Lobaria pulmonaria
Masonhalea richardsonii
Parmelia sulcata
Parmotrema reticulatum
Peltigera aphthosa
Platismatia glauca
Ramalina menziesii
Ramalina sinensis
Rhizoplaca chrysoleuca
Rhizoplaca haydenii
Rhizoplaca idahoensis
Rhizoplaca marginalis
Rhizoplaca melanophthalma
Rhizoplaca peltata
Sphaerophorus globosus
Thamnolia vermicularis
Tuckermanopsis ciliaris
Umbilicaria americana
Umbilicaria mammulata
Usnea hirta
Usnea lapponica
Usnea strigosa
Vulpicida canadensis
Xanthoparmelia chlorochroa
Xanthoparmelia
coloradoënsis
Xanthoparmelia wyomingica

Vulpinic acid
Norstictic acid, Stictic acid Constictic acid, Cryptostictic acid,
Confumarprotocetraric acid
Alectoronic acid
Atranorin, Salazinic acid, Consalazinic acid
Atranorin
Teniorin, Triterpenes
Atranorin, Caperatic acids
Usnic acid
Usnic acid
Usnic acid
Usnic acid
Usnic acid
Usnic acid
Usnic acid, Psoromic acid, Constipatic acid, Dendroconstipatic
acid, Subpsoromic acid
Usnic acid, Atranorin, Pannarin
Phaerophorin
Thamnolic acid, Baeomycesic acid
Protolichesterinic acid
Gyrophoric acid
Gyrophoric acid
Usnic acid, Salazinic acid, Consalazinic acid
Usnic acid
Usnic acid, Norstictic acid, Gallbinic acids
Usnic acid, Vulpinic acid, Zeorin
Usnic acid, Salazinic acid, Consalazinic acid, Norstictic acid
Usnic acid, Norstictic acid, Stictic acid, Constictic acid
Usnic acid, Salazinic acid, Consalazinic acid, Norstictic acid

Antimicrobial activities
MIC values for acetone and methanol extractions of the 36 lichen species against the four
different bacterial strains are reported in Table 3.3. Most of the lichen extracts were found to be
active against three of the four bacteria, P. aeruginosa, S. aureus, and S. aureus COL, while
extracts from only three lichens, Letharia columbiana, L. vulpina, and Vulpicida canadensis
were active against E. coli (Table 3.3). Acetone extractions were found to be more active than
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methanol extractions. MIC values for gentamycin against E. coli, S. aureus, and P. aeruginosa
were all 3.5 µg/ml and for methicillin-resistant S. aureus the MIC was 10 µg/ml. The vehicle
control (DMSO) did not show any activity against the four bacterial strains.
Table 3.3: Minimum Inhibitory Concentration (MIC) values (µg/ml) for different lichens
against four bacteria (A = Acetone; M = Methanol)
Lichens
A. imshaugii
A. sarmentosa
B. fuscescens
C. furcata
E. prunastri
E. catawbiense
F. nivalis
H. physodes
L. columbiana
L. vulpina
L. pulmonaria
M. richardsonii
P. sulcata
P. reticulatum
P. aphthosa
P. glauca
R. menziesii
R. sinensis
R. chrysoleuca
R. haydenii
R. idahoensis
R. marginalis
R. melanophthalma
R. peltata
S. globosus
T. vermicularis
T. ciliaris
U. americana
U. mammulata
U. hirta
U. lapponica

E. coli
A
M
50
125
500
-

P. aeruginosa
A
M
31.25
15.6
31.25
15.6
125
250
31.25
125
250
31.25
15.6
62.5
250
125
125
500
250
500
125
250
250
250
15.6
62.5
15.6
250
7.8
125
3.9
31.25
7.8
31.25
7.8
125
15.6
62.5
15.6
62.5
7.8
31.25
31.25
125
125
500
500
3.9
15.6
15.6
15.6
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S. aureus
A
62.5
62.5
125
500
62.5
125
62.5
62.5
125
3.9
125
250
250
500
15.6
15.6
7.8
15.6
15.6
7.8
15.6
31.25
62.5
125
62.5
500
7.8
15.6

M
62.5
31.25
250
31.25
62.5
500
15.6
125
125
250
31.25
125
250
125
250
500
500
250
31.25
31.25

MRSA
A
250
125
500
500
125
500
500
62.5
31.25
31.25
125
125
250
500
250
62.5
15.6
15.6
15.6
7.8
31.25
31.25
62.5
500
250
7.8
15.6

M
125
62.5
500
62.5
250
125
125
250
500
500
62.5
125
500
250
250
500
500
500
62.5
62.5

U. strigosa
V. canadensis
X. chlorochroa
X. coloradoënsis
X. wyomingica

250
-

-

3.9
15.6
3.9
7.8
15.6

31.25
15.6
62.5
62.5
15.6

7.8
15.6
7.8
7.8
15.6

62.5
62.5
62.5
250
62.5

15.6
31.25
31.25
15.6
62.5

250
125
500
500

Discussion
This study provides data based on the first broad-scale screening of lichens collected
from different parts of the United States against four different pathogenic bacteria.
Since Burkholder et al. (1944) first reported on the antibiotic properties of lichens, a
number of studies have investigated the antimicrobial activities of several lichen species against
various Gram positive, Gram negative and mycobacteria (Burkholder & Evans, 1945; Hobbs,
1986; Ingólfsdóttir et al., 1985; Kokubun et al., 2007a; Lauterwein et al., 1995c; Lawrey, 1989;
Manojlovic et al., 2011; Vartia, 1950). More specifically, studies have shown that lichen
compounds either in crude extract or as purified compounds are not active against gram negative
bacteria such as E. coli and P. aeruginosa (Francolini et al., 2004; Ingólfsdóttir, 2002;
Lauterwein et al., 1995; Melgarejo et al., 2008; Paudel et al., 2012; Yilmaz et al., 2005). In
contrast, there are other studies that show that lichen extracts are active against E. coli (Hoskeri
et al., 2010; Manojlovic et al., 2011; Rankovič et al., 2010) and P. aeruginosa (Hoskeri et al.,
2010; Ingólfsdóttir et al., 1985; Rankovič et al., 2010; Srivastava et al., 2013). In this study we
found most of our lichen extracts inhibited the growth of the gram negative bacterium P.
aeruginosa and extracts from three lichen species, L. columbiana, L. vulpina, and V. canadensis,
were also effective against E. coli. Each of these three lichen species produce vulpinic acid as a
principal secondary metabolite, suggesting that vulpinic acid may be active against E. coli. To
our knowledge there are no data available regarding the antibiotic effects of crude extracts of
Letharia or Vulpicida species or purified vulpinic acid against E. coli except (Lauterwein et al.,
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1995b). However, they were not able to document the antibiotic effects of vulpinic acid against
E. coli at their highest concentration of 32µg/ml. In contrast, in our study, using higher
concentrations of lichen extracts containing vulpinic acid (MIC = 125-250 µg/ml), the growth of
E. coli was inhibited. This variation in the results among different studies may be due to a
combination of factors, including extraction of different lichen species, the solvent used for
extraction, and the specific bacterial strain. Additional research is required to determine the
specific factors influencing antimicrobial properties of lichen extracts.
Our data show that the vast majority of lichen extracts inhibited the drug sensitive strains
of the gram positive bacterium S. aureus in at least one of the tested concentrations. These results
against S. aureus are similar to many other studies (Gulluce et al., 2006; Paudel et al., 2008;
Paudel et al., 2012; Srivastava et al., 2013). We found that all crude extracts of the tested lichen
species except for L. pulmonaria and U. mammulata were found to be active against S. aureus.
Out of the 32 active extracts against S. aureus, acetone extracts of 13 species were generally
more active with MIC values lower than 16 µg/ml, with L. vulpina having the lowest MIC value
at 3.9 µg/ml (Table 3.3). All sampled lichens that were found to be more active against S. aureus
contained usnic acid as the major compound, with the exception of L. vulpina and V. canadensis
which contain vulpinic acid as the major metabolite. A number of previous studies have also
produced results similar to ours, i.e. lichens producing usnic acid demonstrate higher inhibition
against S. aureus (Cocchietto et al., 2002b; Ingólfsdóttir, 2002; Lauterwein et al., 1995;
Ranković et al., 2008).
We also found that most of our lichen extracts were not only capable of inhibiting the
growth of sensitive strains of S. aureus, but also a methicillin-resistant strain of S. aureus.
Various studies have shown similar results (Kokubun et al., 2007; Pompilio et al., 2013).
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Extracts from 9 of our tested lichen species showed relatively low MIC values (<16 µg/ml)
against the methicillin resistant S. aureus and extracts from R. marginalis and U. hirta had the
lowest values at 7.8 µg/ml. Similarly 16 of our lichen extracts showed lower MIC values (<16
µg/ml) against P. aeruginosa while extracts from U. hirta, U. strigosa, R. haydenii, and X.
chlorochroa were most effective with MIC values of 3.8 µg/ml (Table 3.3). Lichen extracts of
species with usnic acid as a major chemical component consistently showed significant higher
activity against S. aureus, P. aeruginosa, as well as the methicillin-resistance S. aureus.
Although both the acetone and methanol extractions demonstrated activity against all of the
bacterial strains except E. coli, the acetone extraction was more active than the methanol
extraction. Several studies (Ranković et al., 2007; Turk et al., 2003; Yilmaz et al., 2005) have
reported the same pattern. Hence it can be concluded that the solvent used in the extraction
process has an effect on the inhibitory strength of the lichen compounds. This phenomenon may
be due to the extraction efficiency of the solvent.
Conclusions
Our study provides evidence that North American lichens represent a potentially
important source of future antibiotic drugs. Our research provides specific evidence indicating
that lichen extracts are effective against both drug sensitive and drug resistant strains of S.
aureus. In particular, extracts from Letharia vulpina, Letharia columbiana, and Vulpicida
canadensis were effective against all bacterial strains tested in this study. These three species
clearly merit further investigation in order to determine their mode of action against bacterial
pathogens and also their levels of cytotoxicity against normal cells.
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Chapter 4: Lichen compound targets cell membrane and cell division processes in methicillinresistant Staphylococcus aureus
Introduction
Antibiotics are naturally-occurring compounds that act specifically to disable vital
cellular functions like cell wall synthesis, cell membrane integrity, and protein synthesis
(Mobashery & Azucena, 2002; Wilson et al., 2011). However, the overuse and frequent misuse
of these ‘miracle drugs’ have strongly selected for drug-resistant strains, as well as given place to
greater incidence of opportunistic and nosocomial infections. One common and frightening
example of an antibiotic-resistant human pathogen is Methicillin-resistant Staphylococcus aureus
(MRSA).
The discovery of new antibacterial drugs has diminished in recent years. The
development of drug-resistant isolates has severely impacted a drug’s long-term potential to
return a profit (Leeb, 2004). Hence, it is necessary to investigate and develop new classes of
antimicrobials that are either opaque to pathogen resistance or express a new mode of action,
thereby increasing the potential lifetime of the antibacterial agent (Kokubun et al., 2007).
Natural products derived from plants, fungi, marine organisms, and microorganism have served
as a rich source of novel biologically active compounds. According to Saleem et al. (2010), more
than 300 new natural metabolites with antimicrobial activities were reported between 2000 and
2008, but there are still many compounds that deserve thorough investigation for their medicinal
properties. Hence, there is a growing interest in phytomedicine, and many medicinally important
plants are being investigated for new antimicrobial agents (Gupta et al., 2012).
Although the antimicrobial properties of lichen compounds have been well documented
(Kantheti et al., 2012; Pompilio et al., 2013; Shrestha & St. Clair, 2013b; Stojanovic et al.,
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2012). However, information regarding the mode of action of these compounds against
pathogenic bacteria is very limited. To our knowledge, there is only one published report on the
mechanism of action of lichen-derived compounds (Gupta et al., 2012). This study reports the
membrane-damaging potential of usnic acid in MRSA.
In this study the mode of action of the crude extracts of L. vulpina against MRSA has
been examined by testing bacteriolytic, bactericidal, and membrane damaging potential of the
extracts.
Materials and methods
Bacterial strain.
MRSA COL used in this study was kindly provided by Dr. Bryan Wilkinson, University
of Illinois.
Lichen materials.
Acetone extract of L. vulpina was used in this study. The extraction and identification of
lichen compounds have been described in chapter 2.
Minimum inhibitory concentration (MIC) assays.
The MIC for L. vulpina extracts was 31.25 µg/ml. The results have been published in
(Shrestha et al., 2014). In this study, we tested three different concentrations (1x MIC, 5x MIC,
and 10x MIC) in an effort to determine the mode of action of the crude extract.
Bacteriolysis.
The effect of L. vulpina extract on cell lysis was evaluated by measuring the OD660 of
treated bacteria at various time points, in accordance with the method described by (Isnansetyo
& Kamei, 2003) with slight modification. Briefly, overnight cultures of MRSA were prepared by
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inoculating 10 ml of Müller Hinton Broth (Sigma Aldrich, St. Louis, MO) with a single MRSA
colony, and incubating at 37 °C with shaking (200 rpm). Then, the culture was diluted with
Müller Hinton broth to an OD660 of approximately 0.1. The bacterial suspensions were treated
with three different concentrations (1x MIC, 5x MIC, and 10x MIC) of L. vulpina extract.
Immediately, samples were taken and the OD660 was measured. Additional samples were taken
and the ODs were measured at 4, 8, 12, 16, and 24 h. Corresponding dilutions of lichen extract
were used as blanks.
Time kill assay
The antimicrobial activities of L. vulpina crude extract against MRSA were evaluated by
measuring the reduction in the numbers of colony forming unit (CFU) over 24 h. Cell
suspensions of MRSA were prepared and treated with lichen extracts as described above.
Viability of bacteria was assessed at various time points (0, 8, 16, and 24 h) by spread-plating
diluted bacterial suspensions onto Müller Hinton agar plate. After 24 h of incubation at 37 °C,
the colonies were counted and data were presented as CFU (% of control) = (number of CFU
lichen extracts/number of CFU control) ×100 (Andra et al., 2008).
Propidium iodide uptake assay
The effect of crude extract of L. vulpina on MRSA membrane permeability was studied
by measuring propidium iodide uptake by bacterial cells. Cell suspensions of MRSA, prepared as
described above, were treated for 24 hours with various concentrations of the extract. The
protocols of (Nobles et al., 2013) were followed with slight modification. Briefly, after 24 h of
treatment, the cells were pelleted by centrifugation and washed once with 1x phosphate buffer
solution (PBS). Ten-fold dilutions of the cell suspensions were made in PBS, and propidium
iodide (50 µg/ml) was added to the cells. A 200 µl aliquot of the cell suspension was transferred
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in triplicate to a 96 well plate, which was incubated at room temperature for 15 min in the dark.
Florescence was measured at excitation and emission wavelengths of 535 and 625 nm,
respectively, using a Synergy HT Multi-Mode Microplate reader (BioTek, Winooski, VT, USA).
Transmission electron microscopy.
In an effort to better understand the membrane damaging properties of these lichen
extract, transmission electron microscopy (TEM) was performed. MRSA suspensions were
treated with the extract of L. vulpina at 10 times the MIC for 24 h at 37°C. This concentration
was chosen in an effort to see the maximum effect on a large percentage of cells. After treatment,
the bacterial cells were pelleted and embedded in 1% low melting point agarose. The cells were
then fixed with 2.5% buffered glutaraldehyde for 1 h, washed with washing buffer, and then
post-fixed in osmium tetroxide for 1 h before final staining en bloc with 1% uranyl acetate
overnight. The buffer used was 0.1M sodium cacodylate, pH 7.4. After overnight staining, cells
were dehydrated in a graded series of acetone, and embedded in epoxy resin. Ultra-thin sections
were prepared and stained with 1% uranyl acetate and lead citrate. Microscopy was performed
with a Tecnai F30 microscope, under standard operating conditions.
Statistical analysis.
All experiments were repeated three times with at least two replicates for each
experiment. The results are reported as mean values ± SD of the three independent runs. Oneway analysis of variance and Dunnett's multiple comparison was applied to determine the
significance of differences in all measured parameters. Statistical analyses were performed using
GraphPad Prism 6 software.
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Results
Extrolites of L. vulpina extract:
To identify compounds present in the extract of L. vulpina thin layer chromatography of
the acetone extracts was performed. Results showed that L. vulpina contained exclusively
vulpinic acid (Fig 4.1).

Vulpinic acid
Figure 4.1: Molecular structure of vulpinic acid identified with thin layer
chromatography, from acetone extracts of L. vulpina
Minimum inhibitory concentration
This study is a follow up study of two previously published studies (Shrestha et al., 2014;
Shrestha & St. Clair, 2013a), wherein acetone and methanol extracts of 36 different lichen
species were screened for activity against four different pathogenic bacteria. In this study we
selected acetone extract of L. vulpina to study their mode of action against MRSA. The MIC
value reported for the extract was 31.25µg/ml. We used three different concentrations: 31.25,
156.25, and 312.5 µg/ml of lichen extracts which represented 1x, 5x, and 10x the MIC,
respectively.
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Bacteriolysis assay
To assess whether the tested lichen extracts have bacteriolytic effect or not, we measured
the OD660 of the treated bacterial culture at various time points. The results obtained from
measuring OD660 revealed a dose and time dependent response by MRSA (Fig 4.2). When
MRSA was treated with 1x MIC and 5x MIC concentrations of L. vulpina extract, there was an
increase in the OD660. However, these increases in the OD660 were still lower than the controls.
The OD660 remained unchanged throughout the experiment when using the 10x MIC of either
lichen extract.

Figure 4.2: Bacteriolytic activity of L. vulpina extract using MRSA.
Bacteriocidal assay
Bacterial cell killing kinetics by lichen extracts were assessed by plating out treated
bacterial suspensions and counting the number of viable cells at different time points. The
treatment of MRSA with the extract showed a reduction in CFU when compared to controls (Fig
4.3). However, the bacterial cell killing kinetics was relatively slow. We observed that there was
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34%, 77%, and 91% reduction in the CFU when treated with 1x MIC, 5x MIC, and 10x MIC of
L. vulpina extract, respectively.

Figure 4.3: Kill kinetics of lichen extracts on MRSA.
Propidium Iodide (PI) uptake assay
To test whether lichen extracts cause membrane instability, we added PI after 24 h of
treatment. Propidium iodide, when associated with DNA, fluoresces intensely and its use in this
context would indicate if the membrane became permeable after lichen extract exposure (ArndtJovin & Jovin, 1989). Our results showed that there was a significant increase (p < 0.05) in the
florescence value when MRSA were treated with 1x MIC, 5x MIC, and 10x MIC of the lichen
extracts (Fig 4.4).
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Figure 4.4: Propidium Iodide uptake by MRSA treated with increasing concentrations of
lichen extracts.
Transmission Electron Microscopy
To further investigate the suspected membrane damaging activities of the lichen extract,
and also to search for evidence of possible additional mechanisms of action, we performed
transmission electron microscopy (TEM) on thin sections of MRSA that had been treated with
10x MIC concentrations of both lichen extracts for 24 h. Untreated cells are shown in Fig 4.5.
Extract of L. vulpina was found to adversely affect the membrane of MRSA causing abnormal
morphology (Fig 4.6). In addition, the extract from L. vulpina also interrupted the normal cell
division process (Fig 4.6 C and D).
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Figure 4.5: Transmission electron micrograph of untreated MRSA.

Figure 4.6: Transmission electron micrograph of MRSA treated with10x MIC
concentrations of L. vulpina. Extract of L. vulpina was found to affect both cell
membrane integrity (Fig 4.6 E and F) and cell division processes (Fig 4.6 B, C, and D)
shown by arrows
Discussion
MRSA isolates have evolved resistance to a range of β-lactam antibiotics, thus limiting
effective treatment options. This condition has resulted in a concerted effort to identify and
develop new potential therapies for treatment of these strains (Stapleton & Taylor, 2002). The
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antimicrobial activity of some lichen compounds indicates promise as a potential solution to this
problem. Since the first report of lichen antimicrobial properties (Burkholder et al., 1944),
several studies have documented the activities of various lichen extracts/chemicals against
different pathogenic bacterial strains. Research (Boustie et al., 2011; Cocchietto et al., 2002a;
Francolini et al., 2004a; Lauterwein et al., 1995c; Molnar & Farkas, 2010b; Pompilio et al.,
2013; Ramos et al., 2014; Ranković et al., 2014; Shrestha & St. Clair, 2013a; Shrestha & St.
Clair, 2013b) has shown that lichen-derived compounds show promise as potentially effective
antibacterial agents. Most of these studies have focused on screening various crude extracts or
isolated lichen compounds against different bacterial strains. However, our research provides
some of the first data describing possible mechanisms of action for lichen extracts against
pathogenic bacterial strains. Specifically, this study provides mechanism of action-related data
for a crude extract from L. vulpina against a MRSA isolate.
Many antimicrobial agents containing polyphenolics cause gross membrane damage and
whole-cell lysis (Sikkema et al., 1995). Our study showed that there was no significant reduction
in the OD660, even at the highest concentration (10x MIC) of the extract after 24 h. This suggests
that the primary mode of action of the lichen-derived polyphenolic compound is not gross cell
membrane damage. We also found steady increases in the absorbance at OD660 with 1x MIC and
5x MIC, however, the absorbance was still lower than the control. (Gupta et al., 2012) also found
increases in the absorbance after a 24 h treatment of MRSA cultures with various concentrations
of usnic acid.
Sub-lethal injury of microbes may alter the permeability of cell membranes and affect the
membrane’s capacity to osmoregulate or to exclude toxic materials (Gilbert, 1984). It appears
that treatment of MRSA cells with this L. vulpina extract was fatal, but the killing kinetics were
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slow. The time kill assay showed that there was a significant reduction in the number of CFUs
after 24 h of exposure. The propidium iodide uptake assay also revealed that there was a dosedependent increase in the uptake of PI by treated cells. Many polyphenolic compounds, derived
either from lichens or higher plants, have given similar results (Alwash et al., 2013; Carson et al.,
2002; Gupta et al., 2012). We found viable bacterial cells after 24 h of treatment, even at the
highest extract concentrations (10x MIC), indicating a slow kill rate. Similar results were also
reported by (Gupta et al., 2012).
Examination of lichen extract-treated MRSA cells using electron microscopy further
documented the inability of this extract to lyse MRSA cells, in spite of clear evidence of damage
to cell membranes. The membrane damaging activity of usnic acid has also been previously
demonstrated (Gupta et al., 2012). Our data also provide preliminary documentation suggesting
that the L. vulpina extract may also affect cell division processes. Many phenolic compounds
have been shown to affect cell division processes in different strains of pathogenic bacteria. FtsZ,
a tubulin-like GTPase, plays a central role in bacterial cell division. Inhibition of FtsZ
polymerization prevents cells from dividing, leading ultimately to cell death (Wang et al., 2003).
Crysophaentin A, a natural phenolic compound isolated from a marine alga, has been shown to
inhibit FtsZ (Plaza et al., 2010). Similarly, another polyphenolic compound, Viriditoxin,
produced by a species of the fungus Aspergillus, also inhibits FtsZ. It is important to mention
here that lichens are symbiotic associations between a fungus and an alga, and they produce an
impressive variety of polyphenolic compounds. Therefore, the results of this study demonstrate
the merits of further biochemical investigations of lichen extracts, as a possible source for new
antibacterial compounds that specifically target cell division processes in MRSA.
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Thin layer chromatography result has shown that L. vulpina contain only vulpinic acid as
its secondary compound. Other published reports also suggest that vulpinic acid is the major
compound present in L. vulpina (Abo-Khatwa et al., 1996; Lawrey, 1983). So, it can be further
inferred that the mode of action we observed in to the crude extract of L. vulpina was due to
vulpinic acid.
Conclusion
A study by Gupta et al. (2012) demonstrated that usnic acid, a commonly occurring
polyphenolic compound in many species of lichens, can destabilize the membrane integrity of
MRSA. Similar to the Gupta study, our results also show that L. vulpina extracts disrupt the
integrity of MRSA membranes. In addition, our data document that L. vulpina extracts also
impact MRSA cell division processes. However, we cannot eliminate the possibility of other
modes of action in addition to destabilizing membranes and disrupting cell division processes,
mediated by this L. vulpina extract. As indicated in the introduction section, there are many
studies showing promising results for the antimicrobial properties of lichen metabolites, but
studies exploring modes of action are very limited. Our study opens the door for future
mechanistic research, and L. vulpina merits further investigation.
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Chapter 5: Examination of the Antioxidant capacity of acetone extracts of North American
lichens using the Oxygen Radical Absorbance Capacity (ORAC) assay
Introduction
Reactive oxygen species (ROS) such as hydrogen peroxide (H2O2), hydroxyl radicals
(OH-), and the superoxide anion (O2-) cause oxidative stress. Oxidation reactions, although
crucial to life, can sometimes have damaging effects on cells often leading to the development of
various chronic diseases like arthritis, cancer, and immunodeficiency syndromes (Kosanić et al.,
2011). Hence a balance between oxidative stress and antioxidants is necessary in living systems.
To effectively deal with the damaging effects of ROS, living organisms maintain a complex
system of antioxidants. Research has shown that antioxidants, obtained either from natural or
synthetic sources, are effective in reducing oxidative damage from ROS in the human body
(Karihtala and Soini, 2007). However, there are reports showing that synthetic antioxidants such
as butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), tert-butylhydroquinone
(TBHQ) and propyl gallate (PG) are toxic and can have carcinogenic effects (Zhang et al., 2009).
For these reasons, recent studies have focused on the screening of natural products for their
antioxidant properties (Naveena et al., 2008). According to Saha et al. (2008), some phenolic
compounds have demonstrated antioxidant properties in biological systems. Lichens produce an
impressive variety of polyphenolic compounds (Shrestha & St. Clair, 2014) therefore, extending
our search for new potentially viable, natural antioxidants to lichens seems prudent.
Lichens have been used for various medicinal purposes since ancient times (Huneck,
1999; Vartia, 1973). For example, Lobaria pulmonaria, Parmelia sulcata, and Letharia
vulpina have been used to treat pulmonary, cranial, and stomach disorders respectively (Huneck,
1999; Kirmizigul et al., 2003; Malhotra et al., 2008). More recently research has shown that
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lichen metabolites demonstrate significant biological activity, including antiviral, antibiotic,
antitumor, antioxidant, anti-herbivory, anti-HIV etc. (Shrestha & St. Clair, 2013b). Of their
various biological properties, their antibiotic and antioxidant potentials have been most
commonly studied.
North America is home to an impressive variety of lichen species. Many studies have
been published examining the taxonomical (Barton et al., 2014; Hutten et al., 2013),
phylogenetic (Leavitt et al., 2013), and ecological (Nelson et al., 2013) aspects of lichens in
North America; however, the biological roles of lichens have been poorly studied.
This study reports on the antioxidant properties of acetone extracts of twelve different
lichen species collected from various parts of the United States. We have used the Oxygen
Radical Absorbance Capacity (ORAC) assay to assess the antioxidant capacity of each lichen
extract.
Materials and Methods
Chemicals
Trolox (6-hydroxy-2,5,7,8-tetramethyl-2-carboxylic acid) was obtained from Enzo Life
Sciences, Inc. (Plymouth, PA). The 2,2'-azobis(2-aminidopropane) dihydrochloride (AAPH) was
purchased from Wako Chemicals USA, Inc. (Richmond, VA), and the Fluorescein-sodium salt,
was purchased from Sigma-Aldrich, Inc. (Milwaukee, WI).
Lichen materials
Samples of twelve species of lichens were collected from various parts of the United
States. Collection information of each lichen species is given in Chapter 2.
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Extraction of lichen compounds
Extraction of lichen compounds is described in Chapter 2.
Oxygen Radical Absorbance Capacity (ORAC) assay
The ORAC assay was performed following the protocol of (Garrett et al., 2010). Five
different concentrations of each lichen extract (50 µg/ml to 3.125 µg/ml) were prepared from the
stock solution (16 mg/ml). Twenty µL of each concentration was then combined with 200 µl of a
0.1061 µM fluorescein solution. A BMG Fluostar Optima plate reader was used to measure
fluorescence at 37 °C over three - 2 minute cycles. Initial fluorescence was determined using
485 nm excitation and 590 nm emission filters. After the first 3 cycles, 20 µL of 26.55mM
AAPH was added to the test solutions. The final concentration of each lichen extract ranged from
4.2 to 0.26 µg/ml after dilution with fluorescein and AAPH. Fluorescence was then measured for
an additional 57 cycles. All fluorescent measurements were expressed relative to the initial gain
adjustment reading. Control samples contained only fluorescein and fluorescein with AAPH.
Trolox is a water-soluble analogue of vitamin E which is used as a standard for antioxidant
experiments. Five different concentrations of trolox standards - 25 µg/ml, 12.5 μg/ml, 6.25
μg/ml, 3.12 μg/ml, and 1.56 μg/ml were used in this study. Fluorescence curves were generated
for all extracts and standards and the area under the curve was calculated to determine the Trolox
Equivalents per microgram (TE/µg) of each lichen extract. The area under the curve (AUC) was
calculated by determining the difference between the area under the fluorescein decay curves and
the area under the sample curve and the fluorescein + AAPH curve. The AUC value indicates the
total antioxidant activity of the sample minus the area under the fluorescein + AAPH antioxidant
curve. Sample fluorescence decay curves of trolox and lichen extracts are shown in Fig 5.1. Each
value is the mean of at least 3 experimental runs each conducted in triplicate.
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Figure 5.1: Sample fluorescence decay curves for controls and different concentrations of
the Parmotrema reticulatum extract.
Results and Discussion
This study reports on the antioxidant capacity of acetone extracts of twelve lichens
species collected from different parts of the United States (Table 3.1). We determined the
antioxidant properties of each lichen extract using the Oxygen Radical Absorbance Capacity
(ORAC) assay. The ORAC assay is a commonly used tool to measure the antioxidant activity of
vitamins, phytochemicals, and other organic and inorganic compounds (Huang et al., 2002). This
assay measures the oxidative degradation of a fluorescent molecule (usually fluorescein-sodium
salt or beta-phycoerythrin) by an oxygen radical initiator such as AAPH (Huang et al., 2005).
With the addition of the oxygen radical initiator, the intensity of the fluorescent molecules begins
to decrease; however, by adding an antioxidant compound you can significantly reduce the rate
at which the fluorescent molecule degrades. Thus, the longer a fluorescent molecule maintains its
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intensity, the more effective the antioxidant compound (Garrett et al., 2010). One important
aspect of the ORAC assay is calculating Trolox Equivalents (TE). Trolox, a water-soluble
vitamin E analogue, is a standard used in antioxidant experiments and its capacity for preventing
oxidation-related damage has been well documented (Hamad et al., 2010). In this study we used
Trolox as our standard for evaluating the antioxidant capacity of lichen extracts.
Our results showed that except for T. vermicularis, all other lichen extracts demonstrated
antioxidant properties (Table 5.1). We also show that out of the twelve lichen extracts, six
species namely, P. reticulatum, M. richardsonii, U. mammulata, R. peltata, E. catawbiense, and
L. pulmonaria reduced the oxidative degradation of the fluorescent molecule by AAPH even at
the lowest extract concentration (0.26 µg/ml). Several reports have already documented the
antioxidant properties of various lichen extracts. Specifically, Ranković et al. (2011) studied the
antioxidant properties of acetone extracts of three lichens – Cladonia furcata, Lecanora atra, and
Lecanora muralis. Results showed that all of the extracts demonstrated antioxidant activity with
Lecanora atra having the highest free radical scavenging capacity. Buçukoglu et al. (2013)
researched the antioxidant activity of methanolic extracts and various purified lichen metabolites
obtained from six Umbilicaria species. All extracts demonstrated moderate DPPH radicalscavenging activity. They also showed that umbilicaric acid had the highest antioxidant activity.
Kumar et al. (2014) evaluated the antioxidant properties of n-hexane, methanol, and water
extracts of fourteen saxicolous (rock) lichens from the trans-Himalayan Ladakh region and
documented that the species tested showed a broad spectrum of free radical scavenging and high
antioxidant capacity. Most studies evaluating the antioxidant properties of lichen compounds
have demonstrated a strong correlation between antioxidant activity and phenolic content
(Brisdelli et al., 2013; Buçukoglu et al., 2013; Ghate et al., 2013; Kosanić et al., 2011).
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Documentation of the major secondary chemicals in the 12 species tested in our study has been
previously published (Shrestha et al., 2014); and all 12 species contained various phenolic
compounds. Phenolic compounds demonstrate strong antioxidant qualities because of their redox
properties, which play an important role in absorbing and neutralizing free radicals, quenching
singlet and triplet oxygen, and decomposing peroxides (Saha et al., 2008). Phenolic compounds
transfer hydrogen to free radicals to break the chain reaction of lipid oxidation at the first
initiation step (Ranković et al., 2011). Hence our results provide strong evidence that the acetone
extracts from the lichen species included in this study have promising antioxidant properties.
Table 5.1: TE/µg values at different concentrations (µg/ml) of lichen extract
Species
P. reticulatum
M. richardsonii
U. mammulata
R. peltata
E. catawbiense
L. pulmonaria
A. sarmentosa
X. wyomingica
C. furcata
L. columbiana
R. sinensis
T. vermicularis

4.2 µg/ml
993.4 ± 54.5
829.1 ± 99.4
794.6 ± 79.2
740.8 ± 54.4
681.5 ± 25.9
529.4 ± 69.5
279.9 ± 39.1
194.5 ± 15.8
160.5 ± 17.6
132.9 ± 18.0
109.6 ± 11.6
-

Antioxidant Value (TE/µg)
2.1 µg/ml
1.05 µg/ml
0.525 µg/ml
536.3 ± 37.5
392.7 ± 11.9
278.4 ± 41.7
462.6 ± 89
243.8 ± 35.2
110 ± 24.2
561.2 ± 12.6
326.2 ± 43.2
179.8 ± 24.1
400.7 ± 70.8
242.1 ± 30.6
115.7 ± 14.8
438.8 ± 51.3
253.8 ± 21.8
181.6 ± 10.9
333.7 ± 68.9
114 ± 25.7
67.4 ± 25.3
158.8 ± 21.1
71.1 ± 12.7
77.8 ± 27.1
121.4 ± 19.9
65.8 ± 20.6
39.5 ± 7.4
99.4 ± 13
53.9 ± 18.2
58.07 ± 6.26
28.5 ± 17
-

0.26 µg/ml
130.8 ± 18.1
23.5 ± 12.5
116.2 ± 46.2
98.7 ± 13.4
68.2 ± 23.3
12.4 ± 6.9
-

We also ranked our 12 lichen species on the basis of TE/μg at 4.2 μg/ml concentration of
the lichen extracts (Fig. 5.2). The three species with the highest antioxidant capacity were P.
reticulatum, M. richardsonii, and U. mammulata with TE/μg, values of 993.4 ± 54.5, 829.1 ±
99.4, and 794.6 ± 79.2 respectively. These three lichen species contained atranorin, alectoronic
acid, and gyrophoric acid, respectively, as major secondary metabolites (Shrestha et al., 2014).
Many lichen species containing atranorin, alectoronic acid, and gyrophoric acid have already
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been screened for their antioxidant properties and have shown positive results (Buçukoglu et al.,
2013; Kosanić et al., 2011; Manojlovic et al., 2012b; Melo et al., 2011; Ravaglia et al., 2014).
The phenolic groups typically associated with lichen metabolites are considered to be key
elements in determining their antioxidative capacity (Marković & Manojlović, 2010). The above
mentioned lichen acids have two or more phenolic groups which likely explains their antioxidant
activity.

Figure 5.2: Comparison of antioxidant capacity (TE/µg) of extracts from twelve lichen
species at 4.2 µg/ml concentration.
In our study the T. vermicularis extract, at the tested concentrations, did not show
antioxidant capacity. However Luo et al. (2006) reported antioxidant activity in methanol
extracts of the same species. These conflicting results might be due to differences in the chemical
extraction process and different assay method used for measuring antioxidant activity.
Based on the current literature, of the twelve species examined in this study six species,
A. sarmentosa, E. catawbiense, M. richardsonii, R. sinensis, R. peltata, and X. wyomingica have
not been previously surveyed for their antioxidant properties.
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In conclusion, of the 12 lichen species considered in this study 11 contain strong
antioxidant compounds; the only exception being T. vermicularis. Considering that antioxidants
are effective therapeutic agents against various serious health issues, our results suggest that
lichen extracts merit further investigation.
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Chapter 6: Anticancer activities of selected species of North American lichen extract against
Burkitt’s lymphoma (Raji cell)
Introduction
Cancer is a disease that circumvents the human immune system, migrates, evolves,
invades organs, destroys tissues, and resists drugs (Mukherjee, 2010). It is the second leading
cause of death in the United States with an estimated 600,000 deaths in 2013. Efforts to combat
various types of cancers have not achieved the expected results in light of the fact that cancer
mortality rates have remained essentially unchanged for the last several decades (Lambert et al.,
2011). Some standard cancer treatments such as chemotherapy, although effective in some
cancers, are inherently problematic with challenging side effects as well as resistance issues. The
need for novel chemotherapeutics has promoted a search for alternative cancer treatments which
are more effective but have fewer side effects.
Natural products, derived from plants, microbes, fungi, and marine have proven to be
promising sources of anticancer drugs (Mondal et al., 2012). Over 60% of the current anticancer
drugs have been developed from natural sources (Cragg & Newman, 2009). However, there are
still many unexamined natural sources that merit further investigation. Among them are lichens.
Lichen chemicals demonstrate various types of biological activity including, antibiotic,
anticancer, antifungal, antioxidant, anti-HIV etc. (Molnár & Farkas, 2010; Shrestha & St. Clair,
2013b; Shukla et al., 2010). Various lichens compounds, either as crude extracts or in purified
form, have been screened against various solid cancer cell lines (Ari et al., 2014; Kumar KC &
Müller, 1999; Mayer et al., 2005; Munzi et al., 2013; Perry et al., 1999; Russo et al., 2012; Takai
et al., 1979; Triggiani et al., 2009). However, studies examining the effectiveness of lichen
compounds against lymphoma have been limited. In this investigation we selected Burkitt’s
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lymphoma (Raji cells) as a model cell line to study the effects of crude lichen extracts and their
mechanism of action against a lymphoma type cancer. Burkitt’s lymphoma is a fast growing
non-Hodgkin’s cancer of the lymphatic system (B lymphocytes). It is a highly aggressive cancer
and often life threatening.
The primary goals of this research are to 1) screen a large number of lichen extracts to
determine their cytotoxic effects against Raji cells and normal lymphocytes and 2) understand
the related mechanism of cell death. Cytotoxicity of lichen extracts was measured using the
trypan blue exclusion method. In order to understand the mechanism of cell death, we studied
cell cycle kinetics, apoptosis, and expression patterns of two genes associated with cancer – the
tumor suppressor gene (p53) and the DNA synthesis and repair gene (TK1).
Materials and Methods
Lichen samples
Seventeen species of lichens were collected from various parts of the United States.
Collection site details are given in chapter 2.
Chemicals
Acetone, dimethyl sulfoxide (DMSO), toluene, ethyl acetate, trypan blue (0.4%),
propidium iodide, and ethanol were purchased from Sigma Aldrich, MO, USA. Formic acid and
L-glutamine were from Fischer Scientific, NJ, USA; Sodium bicarbonate was from Mallinckrodt
chemicals; RNAase from Thermoscientific; and Acridine orange from Life technology, NY,
USA. The cell culture media RPMI-1640, fetal bovine serum (FBS), and phosphate buffer
solution (PBS) were from Hyclone, UT, USA. Thymidine [methyl-3H] was from ViTrax, CA,
USA. RNA extraction kit (RNAqueous, catalog # AM1912) was from Ambion, NY, USA.
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qScript™ One-Step qRT-PCR was used for RT-PCR and purchased from Quanta Bioscience,
MD, USA. Primer for p53 (Hs99999147_m1) and TK1 (Hs00177406_m1) and
phytohaemagglutanin (PHA) was from Invitrogen, NY, USA). Lymphocyte separation media
was bought from Corning, Cellgro, VA, USA. Annexin V-FITC kit (# 4830-01-k) was from
Trevigen, MD, USA. Thin layer chromatographic plates (Silica gel 60 F254) were purchased
from Merck, NJ, USA.
Extraction of lichen compounds
Procedure for extracting of lichen compounds has been described in Chapter 2.
Thin Layer Chromatography:
Thin layer chromatography (TLC) was performed using standard extraction protocol
(Orange et al., 2001).
Cell culture:
Burkitt’s Lymphoma (Raji) cell was used for this study. Raji cells were grown in RPMI1640 supplemented with 10% FBS, L-glutamine (0.2995 mg/L) and Sodium Bicarbonate (1.5
gm/L). Cultures were maintained at 37°C in a humidified 5% CO2 atmosphere. Normal
lymphocytes were obtained from healthy donors with prior consent. Lymphocytes were
separated using lymphocytes separation media (LSM). To separate lymphocytes, blood was first
mixed with PBS in equal ratio and layered on top of LSM in a 50 ml conical vial. The vial was
then centrifuged (400 g, 20 minutes). The buffy layer separated after centrifugation was
collected, washed once with PBS and cultured in RPMI-1640, and phytohaemagglutanin (PHA)
was used to stimulate cell division. Lymphocytes were maintained at 37 °C in a humidified 5%
CO2 atmosphere.
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Cytotoxicity assay
Cytotoxicity was determined using the trypan blue exclusion assay. Raji cells were
seeded at a density of 1 X 105 /ml in a 12 well plate and treated for 48 h at 37 °C with the various
lichen extracts in final concentrations of 0, 6.25, 12.5, 25, and 50 µg/ml. All tests included a
vehicle control with an equivalent concentration of DMSO and doxorubicin, an established
chemotherapeutic drug, was used as a positive control. The final concentration of DMSO did not
exceed 0.32%. After 48 h, cells were counted and viability was assessed using the trypan blue
exclusion assay. Living and dead cells were counted under microscope at 100x magnification.
Cells stained blue with the dye were considered dead and cells not stained with dye were
considered live. IC50 values were calculated by plotting a cell growth curve. Based on the IC50
values, extracts from two lichen species were selected to determine their mechanism of action
against the Raji cell line. To determine the effects of lichen extracts in a broad range, we selected
three different concentrations 15, 25, and 40 µg/ml representing a low to high range of IC50
values and were used in all subsequent experiments. We also tested the cytotoxicity of the two
lichen extracts against normal, dividing human lymphocytes following the same procedures as
described above.
Cell Proliferation
Raji cells were treated with three different concentrations of the two lichen extracts – 15,
25, and 40 µg/ml. After 48 h of treatment, 1 µl/ml of [methyl-3H] thymidine (tritium) with a
specific activity of 185 Gbq/mmol, 5.0 Ci/mmol was added and the culture was incubated for an
additional 4 h at 37°C. An INOTECH cell harvester was then used to extract the radioactively
labeled DNA on glass fiber filter paper and incorporation was determined using the scintillation
counter.
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Cell Cycle Arrest
Raji cells were treated with the various concentrations of each lichen extract. After 48 h,
cells were harvested, washed in cold PBS and fixed in cold 70% ethanol and kept at 4°C
overnight. Fixed cells were then washed again with cold PBS, centrifuged, and incubated for 2 h
at room temperature with RNAse (200 µg/ml) and Propidium Iodide (50 µg/ml). After
incubation, various stages of the cell cycle were analyzed using a FACS Canto flow cytometer
(BD-Biosciences, San Jose, CA) equipped with the CellQuest version 3.3 software. The ModFit
LT version 3.1 program was then used to determine the percentage of cells in the different
phases of the cell cycle.
Biochemical Detection of Apoptosis
Biochemical detection of apoptosis was performed using an Annexin V-FITC kit. Raji
cells were treated for 48 h with various concentrations of each lichen extract. The manufacturer’s
protocol was followed for the detection of apoptosis. After 48 h cells were washed with PBS and
incubated with annexin V-FITC and PI for 15 minutes at room temperature. Samples were then
analyzed using a FACS Canto flow cytometer.
Morphological detection of apoptosis
Morphological detection of apoptosis was accomplished by double staining treated Raji
cells with Acridine orange (100 µg/ml) and Propidium Iodide (100 µg/ml). Pictures were then
taken using Zeiss Imager A.1 florescence microscope. Green cells were considered to be alive,
whereas orange and red cell were identified as apoptotic and necrotic respectively.

66

Gene Expression pattern of p53 and TK1
The effects of lichen extracts on the gene expression pattern of the tumor suppressor gene
(p53) and DNA repair gene (TK1) were studied with Real-time quantitative PCR using an ABI
PRISM 7700 Sequence Detection System (Applied Biosystems, CA, USA). Initially, total RNA
from treated and untreated cells was isolated using an RNAqueous kit. RT-PCR was then
performed using a one-step kit. Amplifications were performed in triplicate for each sample and
PCR conditions were as follows: Initial incubation at 50°C for 10 min, denaturation at 95°C for 1
min, followed by 40 cycles at 95°C for 10 sec, and 60°C for 1 min. We then analyzed the relative
quantitation of gene expression using the comparative CT (ΔΔCT) method (Denman &
McSweeney, 2005). The threshold cycle (CT) was identified as the fractional cycle number at
which the amount of amplified target reached a fix threshold. We then subtracted the CT value of
the ß-actin from the target gene for data normalization. The ΔΔCT was then calculated as the
difference between the normalized CT value (ΔCT) of the treatment and control samples. The
comparative expression levels of the target genes was equal to 2-ΔΔCT.
Statistical Analysis
All experiments were repeated at least three times using separate cell preparations. The
results were reported as mean values ± SD of the three independent runs. One-way analysis of
variance and Dunnett's multiple comparison was applied to determine the significance of
differences in all measured parameters. Statistical analyses were performed using GraphPad
Prism 6 software.

67

Results
Cytotoxicity
To determine the potential role of lichen extracts as anti-cancer agents, we treated Raji
cells with acetone extracts of 17 different lichens at the various concentrations. After 48 h,
extracts from 14 of the 17 lichens species, all except B. fuscescens, U. mammulata, and C.
furcata, effectively reduced the viability of Raji cells at the concentrations tested in a dosedependent manner. The IC50 values for the lichen extracts as well as the positive (Doxorubicin)
and negative (DMSO) controls are reported in Table 6.1. Out of the 14 lichen extracts, – X.
chlorochroa and T. ciliaris had the lowest IC50 values at 28.3±1.4 and 28.4±2.7 µg/ml
respectively. Consequently, we used extracts from these two species to examine the mechanism
behind Raji cell death. We also tested the cytotoxicity of these two lichen extracts against normal
human lymphocytes and found that the viability of the lymphocytes was not affected (viability
>90%) by the treatments.
Extrolites of X. chlorochroa and T. ciliaris
Thin layer chromatography was used to extract and identify the secondary compounds
present in T. ciliaris and X. chlorochroa. Protolichesterinic acid was found in T. ciliaris while X.
chlorochroa contained a mixture of usnic, salazinic, norstictic, and constictic acids.
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Table 6.1: IC50 values (µg/ml) of extracts from 17 species of lichens assessed using the
Trypan Blue assay after 48 h of treatment.
Species
Xanthoparmelia chlorochroa
Tuckermannopsis ciliaris
Rhizoplaca chrysoleuca
Evernastrum catawbiensis
Ramalina menziesii
Alectoria sarmentosa
Peltigera aphthosa
Usnea strigosa
Evernia prunastri
Rhizoplaca peltata
Lobaria pulmonaria
Parmotrema reticulata
Letharia vulpina
Vulpicida canadensis
Bryoria fuscescens
Umbilicaria mammulata
Cladonia furcata
Doxorubicin
DMSO

IC50
28.3±1.4
28.4±2.7
29.2±1.0
29.3±1.6
29.0±2.3
32.4±0.2
33.0±3.4
34.7±2.8
35.8±4.7
36.7±6.8
37.3±3.5
38.2±3.8
43.3±12
43.3±16.6
7.15±1.5
-

Effects on cell proliferation
The effects of the crude extracts of X. chlorochroa and T. ciliaris on proliferation of Raji
cells were examined. In the case of the T. ciliaris extract only the higher concentrations (25 and
40 µg/ml) significantly (p <0.001) reduced the Raji cell proliferation rate but we observed a
significant (p <0.0010 increase with the lowest concentration (15 µg/ml). A dose dependent
response was observed for the X. chlorochroa extract at all concentrations and there was a
significant reduction (p <0.001) in the uptake of thymdine by treatment groups when compared
with control (Fig 6.1).
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A

B
Figure 6.1: Effects of crude extracts of T. ciliaris (A) and X. chlorochroa (B) on
proliferation of Raji cells assessed by the thymidine incorporation assay. * = p <0.05,
** = p <0.01, and *** and **** = p <0.001
Cell cycle arrest
In addition to cell viability and proliferation, we also studied the effects of the two lichen
extracts on the Raji cell cycle. Results of the cell cycle study are shown in Fig 6.2 and 6.3. The
T. ciliaris extract at 25 µg/ml arrested cell growth (p <0.05) at the G0/G1 stage but at the lower
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concentration (15 µg/ml) cell growth did not vary significantly from the control. However, the X.
chlorochroa extract arrested cell growth at G0/G1 stage at both (15 and 25 µg/ml) concentrations
(p <0.01).

A

B

C

Figure 6.2: Results of flow cytometer study showing the number of Raji cells in the
various stages of the cell cycle after treating with T. ciliaris. A = control, B = treated with
15 µg/ml, and C= treated with 25 µg/ml.

A

B

Figure 6 3: Effects of crude extracts of T. ciliaris (A) and X. chlorochroa (B) on cell
cycle dynamics. * = p <0.05 and ** = p <0.01
Apoptosis
To test whether the decrease in cell viability after treatment with the lichen extracts was
due to apoptosis, we used both biochemical and morphological methods for detecting apoptosis.
Our results after 48 h of treatment showed that there was a dose-dependent effect with both
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lichen extracts (Fig 6.4). We found that the percentage of apoptotic cells was 5.2±2.1 in the
control sample while at the highest treatment concentration with the T. ciliaris extract (40 µg/ml)
the percentage of apoptotic cells was 37.2±2.2 for early apoptotic cells and 32.8±5.1 for late
apoptotic cells. Similarly, in the case of the X. chlorochroa extract at the highest treatment
concentration (40 µg/ml) the percentages were 12.9±0.9 and 29.9±0.9 at the early and late
apoptotic stages respectively.

A
B
Figure 6.4: Biochemical detection of apoptosis in Raji cells treated with crude extracts of
T. ciliaris (A) and X. chlorochroa (B).
We also used morphological changes in the Raji cells to detect apoptosis. Our results
showed that treatment with increasing concentrations of either lichen extract resulted in more
orange colored cells indicating apoptosis (Fig 6.5 B and C). Cells treated with the higher extract
concentrations also showed membrane “blebs” which is a hallmark of apoptosis. Control cells
were predominantly green without membrane blebs (Fig 6.5 A) indicating that the cells in the
control samples were alive with no evidence of apoptosis.
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A

B

C

Figure 6.5: Morphological detection of apoptosis in Raji cells treated with T. ciliaris and
X. chlorochroa (both 40 µg/ml) extracts. A – Control, B - T. ciliaris extract and C – X.
chlorochroa extract
Gene expression pattern of p53 and TK1
We also measured the relative expression of the p53 and TK1 genes in the Raji cells
treated with the X. chlorochroa and T. ciliaris extracts as compared to untreated (control) cells
(Table 2). Our results showed that when Raji cells were treated with the T. ciliaris extract, there
was a dose dependent expression of p53 across all extract concentrations. There was also a two
fold increase in the TK1 expression for all T. ciliaris extract concentrations. Similarly, the
expression of p53 was also dose dependent when treated with the X. chlorochroa extract but the
lowest concentration resulted in the highest expression. Expression of TK1 was not affected by
the X. chlorochroa extract treatment.
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Table 6.2: Relative expression of p53 and TK1 gene in treated samples as compared to
control samples
Concentrations
TC40
TC 25
TC 15
XC 40
XC 25
XC 15

Fold increase compared to control
p53
TK1
8.3
2.2
3.5
1.6
2.3
2.0
1.3
1.2
5.0
0.5
11.0
0.8

Discussion
Recently, in the United States there have been extensive research efforts focused on the
ecology, taxonomy, and phylogentics of lichens (Geiser et al., 2010; Leavitt et al., 2012; Leavitt
& St. Clair, 2011; Lendemer & Hodkinson, 2013; McMurray et al., 2013; Shrestha et al., 2012).
However, research reports examining the anticancer properties of North American lichens are
limited. This study presents data examining the cytotoxicity of chemical extracts from 17
different lichen species, collected from different parts of the United States, against Burkitt’s
lymphoma. To the best of our knowledge, none of these lichen species have ever been tested
against any cancer cell lines in crude extract form except for E. prunastri (Triggiani et al., 2009).
We also report the mechanism of action for two lichen extracts against Burkitt’s lymphoma cells.
Our results showed that out of the 17 lichen species tested, extracts of 14 species indicated
activity against Burkitt’s lymphoma at the tested concentrations with IC50 values ranging from
28.3±1.4 to 43.3±16.6 µg/ml. We further demonstrated that lichen extracts have differential
cytotoxicity levels and according to (Bézivin et al., 2003), this may be a useful attribute for
potential anti-tumor agents. Variance in the cytotoxic dose of lichen extracts may in part be due
to the specific combinations of chemicals characteristic of a given species. Similar results
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showing different IC50 values for lichens have been published (Bézivin et al., 2003; Perry et al.,
1999).
Although several attempts have been made to elucidate the mechanism of cell death
caused by lichen metabolites in different cancer cell lines, no reports for Burkitt’s lymphoma
have been published. Therefore, in order to better understand specifically how lichen extracts
impact Burkitt’s lymphoma cells we selected the most potent extracts from two lichens (T.
ciliaris and X. chlorochroa) to examine their mechanism of action.
In this study we found a dose dependent response on the proliferation of Raji cells after
treatment with the different concentrations of the X. chlorochroa extract. The proliferation rate
was significantly lower at all three concentrations when compared with the control. However,
only two concentrations (25 and 40 µg/ml) of the T. ciliaris extract reduced proliferation of Raji
cells significantly when compared to the control. It seems that T. ciliaris at its lower
concentration favors the growth of Raji cell. The difference in the effect of these two lichens
extract can most likely be attributed to differences in the chemical composition of the two
species. For example, X. chlorochroa contains usnic, salazinic, norstitic and constitic acids as its
major compounds while T. ciliaris produces protolichesterinic acid. Various lichen compounds
either in crude or purified forms have been found to reduce the proliferation of various cancer
cell lines (Ari et al., 2012; Liu et al., 2010; Ren et al., 2009; Triggiani et al., 2009). Einarsdottir
et al. (2010) also demonstrated that when compared to untreated cells, treatment with usnic acid
can significantly decrease thymidine uptake in breast (T-47D) and pancreatic (Capan-2) cancer
cells. Similarly Ogmundsdottir et al., (1998) found that protolichesterinic acid also has capacity
to decrease thymidine uptake in erythro-leukemia (K-562). These results suggest that lichen
compounds either as a crude extract or in purified form can act as anti-proliferative agents.
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Our study further documented that the decrease in the proliferation rate of Raji cells after
treatment with both lichen extracts was due to the arrest of cell cycle progression at the G0/G1
phase. Except for treatment with the lowest concentration of the T. ciliaris extract (15 µg/ml), all
other concentrations of both extracts arrested the cell cycle at the G0/G1 phase. Failure to arrest
the cells by T. ciliaris at the lowest concentration seems obvious because at this concentration
proliferation of Raji cells was not affected. There are few published reports which suggest that
lichen compounds are able to arrest the cell cycle at various stages (Backorova et al., 2011; Liu
et al., 2010; Singh et al., 2013). Although the compounds tested in these studies are different
from our studies, the results from these studies shows that lichen compounds have potential to
arrest the cell cycle.
Many studies have shown that lichen compounds induce apoptosis in various cancer cell
lines. For example, Backorova et al., (2011) reported that usnic acid induced apoptosis in human
ovarian carcinoma (A2780), human cervix adenocarcinoma (HeLa), and human colon carcinoma
(HCT-116); while data based on research by (Bezivin et al., 2004; Russo et al., 2012) showed a
dose and time dependent apoptotic response to usnic acid in murine lymphocytic leukemia
(L1210). Protolichesterinic acid has also been found to induce apoptosis in human prostate
cancer cell lines LNCaP and DU-145 (Russo et al., 2012) and HeLa cells (Brisdelli et al., 2013).
In our study we demonstrated that both of our lichen extracts induced apoptosis in Raji cells in a
dose dependent manner. Results of our study are similar to previously published results because
thin layer chromatography showed that usnic acid and protolichesterinic acid are also
consistently present in X. chlorochroa and T. ciliaris respectively.
We also studied the effects of lichen extracts on the expression pattern of two cancerrelated genes – p53 and TK1. Our results showed that both lichen extracts affected expression of
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the p53 gene in a dose dependent manner (Table 2). In addition, when Raji cells were treated
with the T. ciliaris extract, expression of TK1 gene was double the expression rate in the control
cells. This pattern suggests that the T. ciliaris extract may actually stimulate expression of the
TK1 gene. This might be the reason why we found higher thymidine count in Raji cells treated
with the extract of T. ciliaris as compared to the extract of X. chlorochroa. With reference to the
expression of p53, it could be suggested that the apoptotic effect seen in the Raji cells after
treatment with the X. chlorochroa extract was independent of general p53 expression while p53
dependent in the case of the T. ciliaris extract.
Conclusion
In conclusion, we have provided evidences that the crude extracts of two lichen species
X. chlorochroa and T. ciliaris have anti-proliferative effect against Raji cells. Both the extracts
are able to stop the cell cycle at G1 stage and force the cells to undergo apoptosis in p53
dependent and independent manner. Although studies regarding effect of lichen secondary
compounds have been study before; this is the first attempt to study effectiveness of lichen
compounds against lymphoma. This study examined only a small fraction of the potential
anticancer compounds available from the more than 15,000 species of lichens. Considering the
fact that lichens produce a broad spectrum of chemical compounds many of which show
promising levels of biological activity, lichen secondary compounds can realistically be
considered a promising source of future anticancer drugs. However, more detailed in vitro as
well as in vivo studies are necessary to establish the potential anticancer properties of lichen
compounds.
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Chapter 7: Usnic and Vulpinic acid induces caspase-3 independent apoptosis in two colon cancer
cell lines (HT29 and Sw620)
Introduction
According to the American Cancer Society report (2014-16), colorectal cancer is the third
most commonly diagnosed cancer in the United States and the third leading cause of cancerrelated death in both men and women. The report also estimates that there will 136,830 new
cases of colorectal cancer and 50,310 people will die. Modern diets and lifestyles such as high
meat consumption, alcohol use, and limited physical activity can be blamed in part for the
increased mortality rates associated with colon cancer (Kuppusamy et al.,
2014). Epidemiological studies show that there is small, but significant association between fruit
and vegetable intake and a reduction in colorectal cancer risk (Ricciardiello et al., 2011).
Research also shows that diets rich in phenolic compounds may also result in a lower risk of
colon cancer (Yi et al., 2005; Khanal et al., 2011) as well as other types of cancers (Soobrattee et
al., 2006; Huang et al., 2010). In light of these patterns, increased efforts in screening natural
products containing polyphenolic compounds as potential sources for future anticancer drugs
should be a priority.
Lichens produce a diverse and unique group of secondary metabolites including more
than 1050 compounds (Molnar and Farkas, 2010). Polyphenolic compounds comprise one of the
major groups of lichen secondary metabolites. Although initial studies of lichen compounds as
anticancer agents began in the 1960s (Fukuoka and et al., 1968; Nishikawa et al., 1969), only a
limited number have thoroughly examined the potential capacity of lichen compounds as a viable
source of anticancer drugs. As mentioned earlier, natural products containing phenolic
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compounds are considered to be possible sources of anticancer drugs. Therefore, researching
lichen phenolics as a potential source of new anticancer drug therapies seems logical.
In this study we report data based on the screening of acetone extracts of 17 lichen
species against human colon cancer cell line (HT-29). Based on our preliminary data we selected
four lichen compounds, lecanoric, usnic acid, stictic acid, and vulpinic acid, to study their effects
on cell proliferation, cell cycle dynamics, and mode of cellular death in two different colon
cancer cell lines (HT-29 and SW620).
Materials and Methods
Chemicals
Usnic acid, dimethyl sulfoxide (DMSO), and Propidium iodide were purchased from
Sigma Aldrich, MO, USA and stictic, lecanoric and vulpinic acid were purchased from Gaia
Chemical Corporation, CT, USA. The cell culture media DMEM (high glucose) and fetal bovine
serum (FBS) were obtained from Hyclone, UT, USA. RNase was purchased from
Thermoscientific, Waltham, MA; MTT (4890-025-K) and an Annexin V-FITC kit (4830-01-k)
was obtained from Trevigen, MD, USA. Antibodies caspase-3, cleaved caspase-3, and actin were
purchased from Cell Signaling Technology, MA, USA and AIF was obtained from Bioss Inc.
MA, USA.
Lichen samples
Seventeen species of lichens were collected from various parts of the United States
(Table 7.1). Voucher collections of each species have been deposited in the Herbarium of Nonvascular Cryptogams at Brigham Young University, Provo, UT, USA.
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Table 7.1: Lichens used in this study
Lichen species
Alectoria sarmentosa (Ach.) Ach.
Ramalina menziesii Taylor
Bryoria fuscescens (Gyelnik) Brodo & D.
Rhizoplaca chrysoleuca (Sm.) Zopf
Hawksw.
Cladonia furcata (Hudson) Schrader
Rhizoplaca peltata (Ramond) Leuckert &
Poelt
Evernia prunastri (L.) Ach.
Tuckermannopsis ciliaris (Ach.) Gyelnik
Everniastrum catawbiense (Degel.) Hale ex
Umbilicaria mammulata (Ach.) Tuck.
Sipman
Letharia vulpina (L.) Hue
Usnea strigosa (Ach.) Eaton
Lobaria pulmonaria (L.) Hoffm.
Vulpicida canadensis (Räsänen) J.-E. Mattsson
& M. J. Lai
Parmotrema reticulatum (Taylor) M. Choisy Xanthoparmelia chlorochroa (Tuck.) Hale
Peltigera aphthosa (L.) Willd.
Cell culture
Two different colon cancer cell lines- HT29 and SW620 and a normal cell line –Vero
(kidney epithelial cells from an African green monkey) were used in connection with this
experiment. The colon cancer cell lines (HT29 and SW620) and the Vero cell line were grown in
DMEM supplemented with 10% fetal bovine serum (FBS). Cultures were maintained at 37 °C in
a humidified 5% CO2 incubator.
MTT Assay
HT29, SW620, and Vero cells were seeded into 96-well cell culture plates at initial
densities of 3 x 104 cells/well in 100 µl of media. Only the HT29 cells were treated with the
crude lichen extracts for 48 h. While the purified lichen compounds (lecanoric, stictic, usnic,
and vulpinic acids) were used to treat cells (HT29, SW620, and Vero) for 24, 48 and 72 h. Final
concentrations of crude lichen extracts ranged from 6.25 µg/ml to 100 µg/ml while the purified
lichen chemicals (usnic, stictic, lecanoric, and vulpinic acids) were tested at concentrations of
25, 50, 100, and150 µM. DMSO of equivalent concentrations was used as a vehicle control.
After treating all cell lines for the defined time frames, 10 µl of 3-[4,5-dimethylthiazol-2-yl]-2,580

diphenyl tetrazolium bromide (MTT) was added to each cell type and the plates were incubated
for 2 h at 37 °C. After incubation 100 µl of detergent was added to each well and plates were
then incubated for 1 more h at 37 °C. Absorbance (at 570 nm) was then measured.
Cell cycle Analysis
HT29 and SW620 cells were treated with the various concentrations of usnic and vulpinic
acids for 48h. Cells were then harvested, washed in cold PBS and fixed in cold 70% ethanol and
then kept at 4°C overnight. Fixed cells were then washed again with cold PBS, centrifuged, and
incubated for 20 minutes at 37 °C with RNAse (200 µg/ml) and Propidium Iodide (50 µg/ml).
Stages of the cell cycle were then analyzed using an Attune flow cytometer. FlowJO_X (v10)
was used to determine the percentage of cells in the different phases of the cell cycle.
Biochemical Detection of Apoptosis
Annexin V-FITC was used to detect apoptosis after the cells (HT29 and SW620) had
been treated with the various concentrations of usnic and vulpinic acid. The manufacturer’s
protocol was followed for the detection of apoptosis. Briefly, cells were harvest, washed with
PBS, and then incubated with annexin V-FITC and PI for 15 minutes at room temperature.
Samples were then analyzed using an Attune flow cytometer.
Western Blotting
The Western blotting method was used to measure expression of the proteins involved in
apoptosis. The Western blotting technique was performed following the methods of Arroyo et al.
(2009). Both colon cancer cell lines were treated with different concentrations of usnic and
vulpinic acid for various time periods. Cell lysates (50 µg) were separated on a 4–12% Bis-Tris
gel SDS-PAGE and then transferred to a nitrocellulose membrane. The membranes were then
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incubated with antibodies against total Caspase-3 (1: 200), cleaved caspase-3 (1: 200), and the
apoptosis inducing factor (1: 300). Following incubation overnight with primary antibodies, the
membranes were then incubated with a horseradish peroxidase (HRP)-conjugated secondary
antibody for 1 h at room temperature. The membranes were then incubated with an ECL
substrate, and emitted light was detected using x-ray film. To determine loading consistencies,
each membrane was stripped and re-probed with an antibody against rabbit β-actin (dilution
1:4000). Expression levels of the proteins were quantified using densitometry normalized to βactin expression and changes in expression were then compared to untreated controls.
Statistical Analysis
All experiments were repeated at least three times using separate cell preparations.
Results were reported as mean values ± SD of the three independent runs. One-way analysis of
variance and Dunnett's multiple comparison were used to determine the significance of
differences in all measured parameters. Statistical analyses were performed using GraphPad
Prism 6 software.
Results
MTT Assay
The cytotoxicity of acetone extracts obtained from seventeen species of lichens against
HT29 cells were screened using the MTT assay. Among the seventeen species, extracts from
fourteen were found to inhibit the growth of HT29 cells in the tested concentrations. The IC50
values for all the species are reported in Table 7.2. We used thin layer chromatography
techniques (Orange et al., 2001) to identify the major compounds present in the acetone extracts
of all of seventeen lichen species (Table 3.2). Usnic acid was the most common metabolite found
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in seven of the extracts. Therefore, we selected usnic acid to study its mechanism of action
against cancer cell lines. In order to develop a broader understanding about the effects of lichen
compounds on cancer cells we also selected three additional lichen compounds - vulpinic, stictic,
and lecanoric acid. We also added an additional colon cancer cell line (SW680) for our expanded
study.

Usnic acid
Vulpinic acid

Lecanoric acid

Stictic acid

Figure 7.1: Chemical structures of four lichen metabolites used in the experiment.
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Table 7.2: IC50 values (µg/ml) for acetone extracts of the 17 lichen species against HT29 cells
Species
Cladonia furcata
Ramalina menziesii
Rhizoplaca peltata
Rhizoplaca chrysoleuca
Xanthoparmelia chlorochroa
Tuckermannopsis ciliaris
Evernastrum catawbiense
Umbilicaria mammulata
Alectoria sarmentosa
Letharia vulpina
Parmotrema reticulatum
Bryoria fuscescens
Usnea strigosa
Vulpicida canadensis
Evernia prunastri
Lobaria pulmonaria
Peltigera aphthosa

IC50 Values
59.9 ± 3
60.5 ± 6
60 ± 12
61.2 ± 1
64.5 ± 5
68.2 ± 6
69.5 ± 3
75 ± 6
75.2 ± 12
79.1 ± 4
79.8 ± 14
85.9 ± 9
87.5 ± 14
91 ± 20
-

Both usnic and vulpinic acids showed time and dose-dependent anti-proliferative activity
against both cell lines whereas stictic and lecanoric acids demonstrated no anti-proliferative
activity (Fig 7.2 and 7.3).
We also tested the cytotoxicity of usnic and vulpinic acid against normal cells (Vero).
Our results showed that vulpinic acid was not able to reduce proliferation of Vero cells
significantly until 72 h at all tested concentrations while usnic acid, at its highest concentration
(150 uM/ml), significantly reduced the proliferation of vero cells after 72 h. Hence, the highest
concentration of usnic acid was not used for further analyses.
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A

B

C

D

Figure 7.2: Antiproliferative activity of Usnic (A), Vulpinic (B), Stictic (C), and
Lecanoric (D) acids against HT29 as measured using the MTT assay.

A

B
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C

D

Figure 7.3: Antiproliferative activity of Usnic (A), Vulpinic (B), Stictic (C), and
Lecanoric (D) acids against SW620 as measured using the MTT assay.
Cell cycle
To understand the effects of usnic acid and vulpinic acids on cell cycle dynamics, we
used flow cytometric analysis to measure the percentage of cancer cells at the various stages of
the cell cycle. Cells were treated with usnic and vulpinic acid at different concentrations for 48 h
followed by PI staining prior to flow cytometric analysis (Fig 7.4). Usnic and vulpinic acids had
different effects on the two cancer cell lines. When HT29 cells were treated with usnic acid at
100 and 150 µM/ml concentrations, there was a significant (p <0.05) increase in the cell
population at the G2/M stage and a significant decrease in the cell population at the G0/G1 stage
when compared to the control. This result indicates that the usnic acid treated cancer cells were
arrested at the G2/M cell cycle stage (Fig 7.4A). In contrast, when HT29 cells were treated with
vulpinic acid there was an increase in the cell population at the G0/G1 stage but the difference
was not significantly different from the control (Fig 7.4 B). It can be inferred from these results
that vulpinic acid arrests the HT29 cancer cells at the G0/G1 stage. In case of the SW680 cell line,
treatment with usnic acid caused increased accumulation of cells at the G0/G1 stage when
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compared to the control but the increase was not significant (Fig 7.4 C). However, treatment of
the SW620 with vulpinic acid caused the cells to arrest at the S-phase (Fig 7.4 D).
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Figure 7.4: Cell cycle analysis in HT29 (A and B) and SW620 (C and D). Cells were
treated with various concentrations of usnic acid (A and C) vulpinic acid (B and D)
Apoptosis
In order to test whether the decrease in cell proliferation and arrest of the cell cycle
resulted in cell death, we stained the treated cells with Annexin-V and Propidium Iodide and
examined their status using flow cytometry. Results of this experiment showed that there is both
a dose- and time-dependent increase in the apoptotic cell population for both cancer cell lines
(Table 7.3 - 7.6, Fig 7.5 - 7.8). However, in the case of the HT29 cell line, the highest
concentration of usnic acid seemed to cause cell necrosis (Table 7.3 and Fig 7.5).
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Table 7.3: Measuring mode of cell death in HT29 cells treated with usnic acid.
Conc
(µM/ml) ↓
0
25
50
100

Live
24h
91.2±4.6
89.0±5.5
57.1±13.9
38.4±2.7

48h
79.6±4.6
79.4±1.6
50.4±2.7
17.7±0.9

Early Apoptosis
24h
48h
1.8±1.1
1.2±0.1
4.7±1.7
4.4±0.3
21.1±7.9 9.6±1.3
7.0±3.0
3.5±1.8

Late Apoptosis
24h
48h
6.0±4.5
10.9±1.7
6.1±3.0
12.1±1.3
18.2±5.2
19.5±3.2
11.1±3.3 26.0±12.9

Necrotic
24h
48h
1.2±1.0
8.4±5.2
0.7±0.4
4.3±1.7
3.6±2.1
20.9±5.0
43.6±8.5 52.9±13.8

Figure 7.5: Flow cytometry analysis of HT29 cells treated with various concentration of
usnic acid.

Table 7.4: Measuring mode of cell death in HT29 cells treated with vulpinc acid.
Conc
(µM/ml) ↓
0
50
100
150

Live

48h
88.9±0.6
85.7±0.5
86.0±1.4
71.7±8.1

72h
82.9±4.2
74.7±1.6
68.1±4.1
59.7±4.1

Early Apoptosis
Late Apoptosis
48h
72h
48h
72h
1.1±0.3 1.2±0.1 4.3±0.5 10.9±1.7
1.2±0.1 1.6±0.1 4.8±0.2 11.4±0.5
1.1±0.2 13.2±2.8 5.4±1.5 11.9±4.1
1.7±0.8 17.4±7.5 16.9±2.1 17.7±4.1

Necrotic
48h
72h
5.6±0.9 5.0±2.5
8.3±0.5 13.0±2.1
7.4±0.8 6.8±1.0
9.6±5.5 5.2±2.2

Figure 7.6: Flow cytometry analysis of HT29 cells treated with various concentration of
vulpinic acid.
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Table 7.5: Measuring mode of cell death in SW620 cells treated with usnic acid
Concn
(µM/ml) ↓
0
25
50
100

Live

24h
92.4±1.1
72.0±5.0
68.5±1.1
65.3±6.7

48h
91.7±1.7
84.9±5.1
56.9±1.4
17.8±3.2

Early apoptosis
Late Apoptosis
Necrotic
24h
48h
24h
48h
24h
48h
2.1±0.7 1.8±1.1 2.5±0.6 2.5±0.2 2.9±0.2 4.0±0.9
2.6±0.2 5.4±3.6 18.6±4.8 7.4±2.4 6.7±2.5 2.4±2.3
2.5±0.2 11.7±5.7 22.2±1.9 22.4±1.5 6.7±1.7 9.1±5.7
4.8±1.4 38.5±4.5 25.5±8.0 39.4±2.0 6.1±2.7 4.2±2.5

Figure 7.7: Flow cytometry analysis of SW620 cells treated with various concentrations
of usnic acid.
Table 7.6: Measuring mode of cell death in SW620 cells treated with vulpinic acid
Concn
(µM/ml) ↓
0
50
100
150

Live

48h
92.6±2.0
92.4±1.4
90.1±0.8
89.3±0.4

72h
85.5±3.8
79.0±1.8
68.6±7.0
44.2±4.4

Early apoptosis
48h
72h
0.7±0.6 3.2±0.5
0.6±0.6 3.3±0.3
1.4±0.7 5.2±0.5
1.6±1.1 9.8±2.0

Late Apoptosis
48h
72h
1.9±1.7 7.8±1.4
1.7±1.7 14.7±1.5
3.8±1.2 22.3±5.5
4.1±2.5 39.3±3.7

Necrotic
48h
72h
4.8±0.4 3.2±2.0
5.5±1.0 2.9±0.6
4.9±2.9 3.4±1.6
5.0±3.2 6.8±2.2

Figure 7.8: Flow cytometry analysis of SW620 cells treated with various concentrations
of vulpinic acid.
89

Western Blotting
Caspases are key mediators of programmed cell death (apoptosis). Caspase-3 is an
effector caspase that is activated through cleavage by caspase-9. We analyzed cell extracts for
activation of caspase-3 and cleaved-caspase-3 after treatment with usnic acid for 48 h and
vulpinic acid for 72 h. We did not include the 100 µM/ml concentration of usnic acid in HT29
cell treatment because this concentration appeared to be toxic. Caspase-3 was present in all
samples including the control (Fig 7.9 and 7.10) but there was no expression of cleaved-caspase3 suggesting that apoptosis had occurred independent of caspase-3. Apoptosis can occur
independent of casapase-3 activation and it has been shown that apoptosis inducing factor (AIF)
is involved in the induction of apoptotic cell death via a caspase-independent pathway (Ren et al.
2009). When cells receive a death stimulus, Mitochondrial AIF is release and translocated into
the nucleus causing nuclear condensation. Therefore, we analyzed changes in AIF levels using
the Western blotting method to determine whether or not AIF played a role in apoptotic cell
death. When HT29 cells were treated with usnic acid, AIF was stimulated by a 2.2 and 3.2-fold
at 50 and 100 µM/ml concentrations respectively compared to the control. Similarly, treatment of
HT29 with vulpinic acid stimulated AIF by a 1.9, 2.2, and 2.3- fold at 50, 100, and 150 µM/ml
concentrations respectively compared to the control. In SW620 cell lines there was also a
marked increase in the expression of AIF in treated cells when compared to the control. When
SW620 cells were treated with usnic acid at 25, 50, and 100 µM/ml concentrations there was a
1.3, 1.7, and 2.3-fold increase in the expression of AIF respectively and similarly with vulpinic
acid there was a 1.3, 1.3, and 1.5-fold increases in the expression of AIF with concentrations of
50, 100, and 150 µM/ml of vulpinic acid respectively.
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Usnic Acid

Vulpinic Acid

Figure 7.9: Expression levels of AIF, Caspase 3, and β-actin proteins in usnic and
vulpinic acid treated HT29 cells using Western blot analysis.

Usnic Acid

Vulpinic Acid

Figure 7.10: Expression levels of AIF, Caspase 3, and β-actin proteins in usnic and
vulpinic acid treated SW620 cells using Western blot analysis.
Discussion
Secondary compounds from various natural sources, including lichens, represent a
promising reservoir of various kinds of therapeutic drugs. For example, several lichen secondary
metabolites have demonstrated potential as antibiotics and anticancer drugs. (Shrestha & Clair,
2013). In this study we screened acetone extracts of 17 different lichen species against the HT29

91

colon cancer cell line. For most of the lichen species screened this represents the first time these
extracts have been tested against this cancer cell line. TLC analysis of the extract guided us to
examine the potential effects of four different purified lichen compounds namely, lecanoric,
stictic, vulpinic, and usnic acids against two colon cancer cell lines - HT29 and SW620. This
report represents the initial attempt to determine the effects of the above lichen compounds on
the SW620 cancer cell line.
Our data show that both leconaric and stictic acids had no significant effect on the
proliferation of either cancer cell lines while both usnic and vulpinic acids show both a dose- and
time-dependent response against both cancer cell lines. The data clearly show that usnic acid is
more effective in reducing proliferation of both types of cancer cells than vulpinic acid. Our data
also show that both usnic and vulpinic acids are relatively non-toxic to normal cells (Vero).
Usnic acid is one of the most extensively studied lichen metabolites and a number of studies
have shown that usnic acid is effective as an anti-cancer agent against an impressive range of
cancer cell lines (Backorova et al., 2012). Compared to usnic acid, vulpinic acid has been poorly
studied. To date, research has shown that vulpinic acid expresses intermediate cytotoxicity
against MM98 malignant mesothelioma cells, A431 vulvar carcinoma cells, and HaCaT
keratinocytes (Burlando et al., 2009).
More specifically, our data show that the decrease in the proliferation rate of cancer cells
after treatment with usnic and vulpinic acids is due to cell cycle arrest. However, usnic and
vulpinic acids exhibited variable responses in terms of cell cycle arrest as shown by accumulated
cell population at different cell cycle stages for both cancer cell lines. Usnic acid arrests the cell
cycle at the G2/M stage in the HT29 cell line resulting in the accumulation of the cancer cell
population at the G0/G1stage. Whereas, vulpinic acid arrests HT29 cells at the S stage and
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SW620 cells at G0/G1 stage. Usnic acid is known to arrest the cell cycle at various stages in
different cancer cell lines. For example, Singh et al. (2013) reported that usnic acid arrests A549
cancer cells at the G0/G1 stage and as reported by Backorova et al. (2011) usnic acid also arrests
cells at the S phase in several different cancer cell lines.
One of the hallmarks of apoptosis is the externalization of phosphatidylserine as a
consequence of loss in cell membrane asymmetry, a condition which can be measured before the
loss of membrane integrity (Mikes et al., 2009). The externalization of phosphatidylserine can be
determined using flow cytometry by measuring the quantity of the protein, Annexin V which
binds to the membrane. Our results show that there is an increase in the percentage of Annexin V
bound cells with both increasing concentrations of lichen metabolites as well as exposure time.
The data also indicate that the higher concentration of usnic acid (100 µM/ml) was toxic to the
HT29 cell line causing necrosis instead of apoptosis. Whereas with the SW620 cell line the
higher concentrations of usnic acid increased the percentage of apoptotic cells without causing
necrosis. Similarly vulpinic acid also resulted in apoptosis in both a dose and time dependent
manner for both cancer cell lines. Other researchers have also shown that crude lichen extracts as
well as purified lichen metabolites will induce apoptosis in various cancer cell lines. For
example, Nguyen et al. (2014) showed that crude acetone extracts of Flavocetraria cucullata and
its isolated compound, usnic acid, induced apoptosis in colon cancer (HT29), gastric cancer
(AGS), lung cancer (A549), and prostate cancer (CWR22Rv-1) cell lines. They also reported
increasing levels of apoptotic proteins like Bax, cleaved PARP, and cleaved caspase-3 in all
tested cancer cell lines as well as a significant decrease in the anti-apoptotic protein Bcl-xL.
Induction of apoptosis by acetone extracts from the lichen Lethariella zahlbruckneri was
reported by Ren et al. (2009). The secondary compounds of L. zahlbruckneri include vulpinic
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acid as well as other depsides and aliphatic acids (Obermayer, 1997). Ren et al. (2009) also
found that the induction of apoptosis was associated with the activation of initiator caspases-8
and -9, as well as the effector caspase-3, an increase in the expression of the pro-apoptotic
protein Bax, and a decrease in the expression of the anti-apoptotic protein Bcl-2.
Caspases are a group of intracellular proteases which are responsible for the deliberate
disassembly of the cell into apoptotic bodies during apoptosis (Thornberry & Lazebnik,
1998). Caspases are present as inactive pro-enzymes that are activated by proteolytic cleavage.
In our study we were unable to detect expression of cleaved caspase-3 however we did find
expression of caspase-3 in all treatment as well as controls. This result suggests that in some
cases apoptosis can occur independent of caspase-3. In our study we found that the treatment of
HT29 and SW620 cancer cell lines with usnic and vulpinic acid increased the expression of the
AIF protein when compared to the control sample. AIF is a mitochondrial apoptosis inducing
factor which translocates to the nucleus, in response to apototic stimuli, where it causes partial
DNA fragmentation and chromatin condensation (Ren et al., 2009).
In summary, both usnic and vulpinic acids show promise as potential anti-cancer
compounds while lecanoric and stictic acids showed no anti-proliferative action at the tested
concentrations. We found that usnic and vulpinic acids arrested the cell cycle in both of the
tested cancer cell lines but at different cell cycle stages while externalizing the
phosphatidylserine protein and inducing apoptosis independent of caspase-3.
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